Expression	O
of	O
A-myb	B-DNA
,	O
but	O
not	O
c-myb	B-DNA
and	O
B-myb	B-DNA
,	O
is	O
restricted	O
to	O
Burkitt	O
's	O
lymphoma	O
,	O
sIg+	O
B-acute	O
lymphoblastic	O
leukemia	O
,	O
and	O
a	O
subset	O
of	O
chronic	O
lymphocytic	O
leukemias	O
.	O

The	O
A-myb	B-DNA
gene	I-DNA
encodes	O
a	O
transcription	B-protein
factor	I-protein
that	O
is	O
related	O
both	O
functionally	O
and	O
structurally	O
to	O
the	O
v-myb	B-DNA
oncogene	I-DNA
.	O

Following	O
our	O
observations	O
that	O
A-myb	B-DNA
is	O
expressed	O
in	O
a	O
restricted	O
subset	O
of	O
normal	O
mature	B-cell_type
human	I-cell_type
B	I-cell_type
lymphocytes	I-cell_type
,	O
with	O
the	O
phenotype	O
CD38+	O
,	O
CD39-	O
,	O
slgM-	O
,	O
we	O
have	O
now	O
investigated	O
the	O
pattern	O
of	O
A-myb	B-DNA
expression	O
in	O
neoplastic	O
B	B-cell_type
cells	I-cell_type
representating	O
the	O
whole	O
spectrum	O
of	O
B-cell	O
differentiation	O
and	O
compared	O
it	O
to	O
that	O
of	O
c-myb	B-DNA
and	O
B-myb	B-DNA
.	O

In	O
a	O
panel	O
of	O
32	O
B-cell	B-cell_line
lines	I-cell_line
,	O
A-myb	B-DNA
was	O
very	O
strongly	O
expressed	O
in	O
most	O
Burkitt	O
's	O
lymphoma	O
(	O
BL	O
)	O
cell	O
lines	O
,	O
but	O
weak	O
or	O
negative	O
in	O
2	O
pre-B	O
acute	O
lymphoblastic	O
leukemia	O
(	O
ALL	O
)	O
,	O
4	O
non-Hodgkin	O
's	O
lymphoma	O
(	O
NHL	O
)	O
,	O
6	O
Epstein-Barr	B-cell_line
virus-immortalized	I-cell_line
lymphoblastoid	I-cell_line
cell	I-cell_line
lines	I-cell_line
,	O
and	O
6	O
myeloma	B-cell_line
lines	I-cell_line
.	O

Protein	O
expression	O
paralleled	O
that	O
of	O
the	O
RNA	O
.	O

We	O
have	O
also	O
investigated	O
A-myb	B-DNA
expression	O
in	O
49	O
fresh	O
cases	O
of	O
B	O
leukemias	O
.	O

Among	O
24	O
ALL	O
,	O
6	O
were	O
of	O
the	O
null	O
and	O
11	O
of	O
the	O
common	O
type	O
and	O
all	O
these	O
were	O
negative	O
for	O
A-myb	B-protein
expression	O
;	O
on	O
the	O
other	O
hand	O
,	O
all	O
7	O
B-ALL	O
cases	O
(	O
slg+	O
)	O
,	O
as	O
well	O
as	O
one	O
fresh	O
BL	O
case	O
with	O
bone	O
marrow	O
infiltration	O
,	O
expressed	O
A-myb	B-DNA
.	O

A-myb	B-DNA
was	O
undetectable	O
in	O
4	O
prolymphocytic	O
leukemias	O
(	O
PLL	O
)	O
but	O
was	O
strongly	O
expressed	O
in	O
5/20	O
(	O
25	O
%	O
)	O
of	O
chronic	O
lymphocytic	O
leukemia	O
(	O
CLL	O
)	O
samples	O
.	O

In	O
the	O
latter	O
A-myb	B-DNA
did	O
not	O
correlate	O
with	O
phenotype	O
or	O
clinical	O
stage	O
.	O

Finally	O
,	O
we	O
have	O
studied	O
the	O
progression	O
of	O
one	O
case	O
of	O
CLL	O
into	O
Richter	O
's	O
syndrome	O
and	O
have	O
found	O
that	O
the	O
Richter	B-cell_line
's	I-cell_line
cells	I-cell_line
expressed	O
about	O
25-fold	O
less	O
A-myb	B-RNA
RNA	I-RNA
than	O
the	O
CLL	B-cell_line
cells	I-cell_line
from	O
the	O
same	O
patient.	O
The	O
pattern	O
of	O
c-myb	B-DNA
and	O
B-myb	B-DNA
was	O
clearly	O
distinct	O
from	O
that	O
of	O
A-myb	B-DNA
.	O

C-myb	O
and	O
B-myb	B-DNA
were	O
expressed	O
in	O
all	O
neoplastic	O
groups	O
,	O
except	O
in	O
CLL	B-cell_line
cells	I-cell_line
.	O

Thus	O
,	O
A-myb	B-DNA
expression	O
,	O
unlike	O
that	O
of	O
c-myb	B-DNA
and	O
B-myb	B-DNA
,	O
is	O
restricted	O
to	O
a	O
subset	O
of	O
B-cell	O
neoplasias	O
(	O
in	O
particular	O
BL	O
and	O
slg+B-ALL	O
)	O
representative	O
of	O
a	O
specific	O
stage	O
of	O
B-cell	O
differentiation	O
.	O

This	O
expression	O
may	O
in	O
part	O
reflect	O
expression	O
of	O
A-myb	B-DNA
by	O
the	O
normal	O
germinal	O
center	O
B	B-cell_type
cells	I-cell_type
that	O
are	O
the	O
normal	O
counterpart	O
of	O
these	O
transformed	B-cell_line
B	I-cell_line
cells	I-cell_line
.	O

The	O
data	O
presented	O
strongly	O
support	O
a	O
role	O
for	O
this	O
transcription	B-protein
factor	I-protein
in	O
B-cell	O
differentiation	O
and	O
perhaps	O
in	O
B-cell	O
transformation	O
in	O
some	O
neoplasias	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Expression	NULL
of	NULL
A-myb	NULL
,	NULL
But	NULL
Not	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
Is	NULL
Restricted	NULL
To	NULL
Burkitt	NULL
's	NULL
Lymphoma	NULL
,	NULL
slg*	NULL
B-Acute	NULL
Lymphoblastic	NULL
Leukemia	NULL
,	NULL
and	NULL
a	NULL
Subset	NULL
of	NULL
Chronic	NULL
Lymphocytic	NULL
Leukemias	NULL
By	NULL
J.	NULL
Golay	NULL
,	NULL
M.	NULL
Luppi	NULL
,	NULL
S.	NULL
Songia	NULL
,	NULL
C.	NULL
Palvarini	NULL
,	NULL
L.	NULL
Lombardi	NULL
,	NULL
A.	NULL
Aiello	NULL
,	NULL
D.	NULL
Delia	NULL
,	NULL
K.	NULL
Lam	NULL
,	NULL
D.H.	NULL
Crawford	NULL
,	NULL
A.	NULL
Biondi	NULL
,	NULL
T.	NULL
Barbui	NULL
,	NULL
A.	NULL
Rambaldi	NULL
,	NULL
and	NULL
M.	NULL
Introna	NULL
The	NULL
A-myb	NULL
gene	NULL
encodes	NULL
a	NULL
transcription	NULL
factor	NULL
that	NULL
is	NULL
related	NULL
both	NULL
functionally	NULL
and	NULL
structurally	NULL
to	NULL
the	NULL
v-myb	NULL
oncogene	NULL
.	NULL

Following	NULL
our	NULL
observations	NULL
that	NULL
A-myb	NULL
is	NULL
expressed	NULL
in	NULL
a	NULL
restricted	NULL
subset	NULL
of	NULL
normal	NULL
mature	NULL
human	NULL
B	NULL
lymphocytes	NULL
,	NULL
with	NULL
the	NULL
phenotype	NULL
CD38*	NULL
,	NULL
CD397	NULL
,	NULL
sigM~	NULL
,	NULL
we	NULL
have	NULL
now	NULL
investigated	NULL
the	NULL
pattern	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
representing	NULL
the	NULL
whole	NULL
spectrum	NULL
of	NULL
B-cell	NULL
differentiation	NULL
and	NULL
compared	NULL
it	NULL
to	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
.	NULL

In	NULL
a	NULL
panel	NULL
of	NULL
32	NULL
B-cell	NULL
lines	NULL
,	NULL
A-myb	NULL
was	NULL
very	NULL
strongly	NULL
expressed	NULL
in	NULL
most	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
}	NULL
cell	NULL
lines	NULL
,	NULL
but	NULL
weak	NULL
or	NULL
negative	NULL
in	NULL
2	NULL
pre-B	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
ALL	NULL
)	NULL
,	NULL
4	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
(	NULL
NHL	NULL
)	NULL
,	NULL
6	NULL
Epstein-Barr	NULL
virus-immortalized	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
and	NULL
6	NULL
myeloma	NULL
lines	NULL
.	NULL

Protein	NULL
expression	NULL
paralleled	NULL
that	NULL
of	NULL
the	NULL
RNA	NULL
.	NULL

We	NULL
have	NULL
also	NULL
investigated	NULL
A-myb	NULL
expression	NULL
in	NULL
49	NULL
fresh	NULL
cases	NULL
of	NULL
B	NULL
leukemias	NULL
.	NULL

Among	NULL
24	NULL
ALL	NULL
,	NULL
6	NULL
were	NULL
of	NULL
the	NULL
null	NULL
and	NULL
11	NULL
of	NULL
the	NULL
common	NULL
type	NULL
and	NULL
all	NULL
these	NULL
were	NULL
negative	NULL
for	NULL
A-myb	NULL
expression	NULL
;	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
all	NULL
7	NULL
B-ALL	NULL
cases	NULL
(	NULL
sig*	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
one	NULL
fresh	NULL
BL	NULL
case	NULL
with	NULL
bone	NULL
marrow	NULL
infiltration	NULL
,	NULL
expressed	NULL
A-myb	NULL
.	NULL

A-myb	NULL
was	NULL
undetectable	NULL
in	NULL
4	NULL
prolymphocytic	NULL
leukemias	NULL
(	NULL
PLL	NULL
)	NULL
but	NULL
was	NULL
HE	NULL
A-myb	NULL
gene	NULL
belongs	NULL
to	NULL
the	NULL
myb	NULL
gene	NULL
family	NULL
.	NULL
``	NULL

''	NULL
This	NULL
family	NULL
includes	NULL
the	NULL
v-myb	NULL
oncogene	NULL
which	NULL
is	NULL
carried	NULL
by	NULL
the	NULL
avian	NULL
retroviruses	NULL
AMV	NULL
and	NULL
E26	NULL
and	NULL
which	NULL
transforms	NULL
cells	NULL
of	NULL
hematopoietic	NULL
origin	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
in	NULL
the	NULL
chicken	NULL
.	NULL
``	NULL

The	NULL
cellular	NULL
counterpart	NULL
of	NULL
v-myb	NULL
is	NULL
the	NULL
c-myb	NULL
proto-oncogene	NULL
,	NULL
which	NULL
has	NULL
been	NULL
directly	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
hematopoietic	NULL
proliferation	NULL
and	NULL
differentia-tion	NULL
.	NULL
``	NULL

''	NULL
C-myb	NULL
expression	NULL
is	NULL
mostly	NULL
restricted	NULL
to	NULL
the	NULL
hematopoietic	NULL
system	NULL
and	NULL
correlates	NULL
with	NULL
both	NULL
the	NULL
immaturity	NULL
and/	NULL
or	NULL
the	NULL
proliferative	NULL
state	NULL
of	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

Both	NULL
v-myb	NULL
and	NULL
c-myb	NULL
are	NULL
transcription	NULL
factors	NULL
.	NULL
``	NULL

''	NULL
They	NULL
bind	NULL
to	NULL
a	NULL
specific	NULL
DNA	NULL
sequence	NULL
(	NULL
PyAACG/TG	NULL
)	NULL
and	NULL
activate	NULL
transcription	NULL
downstream	NULL
of	NULL
such	NULL
sequences	NULL
.	NULL

'*	NULL
The	NULL
transcriptional	NULL
activity	NULL
From	NULL
Istituto	NULL
Ricerche	NULL
Farmacologiche	NULL
``	NULL
Mario	NULL
Negri	NULL
,	NULL
``	NULL
Milan	NULL
;	NULL
Clinica	NULL
Medica	NULL
Generale	NULL
e	NULL
Terapia	NULL
Medica	NULL
II	NULL
,	NULL
University	NULL
of	NULL
Mo-dena	NULL
;	NULL
Hematology	NULL
Service	NULL
,	NULL
Insitute	NULL
of	NULL
Medical	NULL
Sciences	NULL
,	NULL
Ospedale	NULL
Maggiore	NULL
LR.C.C.S	NULL
.	NULL

,	NULL
Milan	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Experimental	NULL
Oncology	NULL
,	NULL
National	NULL
Institute	NULL
for	NULL
the	NULL
Study	NULL
and	NULL
Cure	NULL
of	NULL
Tumors	NULL
,	NULL
Milan	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Pediatrics	NULL
,	NULL
Hospital	NULL
San	NULL
Gerardo	NULL
,	NULL
Monza	NULL
;	NULL
the	NULL
Division	NULL
of	NULL
Hematology	NULL
,	NULL
Ospedali	NULL
Riuniti	NULL
,	NULL
Bergamo	NULL
,	NULL
Italy	NULL
;	NULL
and	NULL
the	NULL
Department	NULL
of	NULL
Clinical	NULL
Sciences	NULL
,	NULL
London	NULL
School	NULL
of	NULL
Hygiene	NULL
and	NULL
Tropical	NULL
Medicine	NULL
,	NULL
Keppel	NULL
Street	NULL
,	NULL
London	NULL
,	NULL
UK	NULL
.	NULL

Submitted	NULL
April	NULL
18	NULL
,	NULL
1995	NULL
;	NULL
accepted	NULL
October	NULL
2	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
Italian	NULL
Association	NULL
for	NULL
Cancer	NULL
Research	NULL
(	NULL
AIRC	NULL
)	NULL
,	NULL
the	NULL
National	NULL
Research	NULL
Council	NULL
(	NULL
C.N.R	NULL
.	NULL

,	NULL
progetto	NULL
A.C.R.O	NULL
.	NULL

and	NULL
bilateral	NULL
project	NULL
with	NULL
D.H.C	NULL
.	NULL
)	NULL

.	NULL

J.G	NULL
.	NULL

is	NULL
supported	NULL
by	NULL
the	NULL
Istituto	NULL
Superiore	NULL
di	NULL
Sanita	NULL
(	NULL
AIDS	NULL
grants	NULL
)	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
J.	NULL
Golay	NULL
,	NULL
PhD	NULL
,	NULL
Istituto	NULL
Ricerche	NULL
Farmacologiche	NULL
``	NULL
Mario	NULL
Negri	NULL
,	NULL
``	NULL
Via	NULL
Eritrea	NULL
62	NULL
,	NULL
20157	NULL
Milan	NULL
,	NULL
Italy	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-497	NULL
1/96/8705-0049	NULL
$	NULL
3.00/0	NULL
1900	NULL
strongly	NULL
expressed	NULL
in	NULL
5/20	NULL
(	NULL
25	NULL
%	NULL
)	NULL
of	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
CLL	NULL
)	NULL
samples	NULL
.	NULL

In	NULL
the	NULL
latter	NULL
A-myb	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
phenotype	NULL
or	NULL
clinical	NULL
stage	NULL
.	NULL

Finally	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
progression	NULL
of	NULL
one	NULL
case	NULL
of	NULL
CLL	NULL
into	NULL
Richter	NULL
's	NULL
syndrome	NULL
and	NULL
have	NULL
found	NULL
that	NULL
the	NULL
Richter	NULL
's	NULL
cells	NULL
expressed	NULL
about	NULL
25-fold	NULL
less	NULL
A-myb	NULL
RNA	NULL
than	NULL
the	NULL
CLL	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
was	NULL
clearly	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
A-myb	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
were	NULL
expressed	NULL
in	NULL
all	NULL
neoplastic	NULL
groups	NULL
,	NULL
except	NULL
in	NULL
CLL	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
A-myb	NULL
expression	NULL
,	NULL
unlike	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
subset	NULL
of	NULL
B-cell	NULL
neoplasias	NULL
(	NULL
in	NULL
particular	NULL
BL	NULL
and	NULL
sig	NULL
*	NULL
B-ALL	NULL
}	NULL
representative	NULL
of	NULL
a	NULL
specific	NULL
stage	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

This	NULL
expression	NULL
may	NULL
in	NULL
part	NULL
reflect	NULL
expression	NULL
of	NULL
A-myb	NULL
by	NULL
the	NULL
normal	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
that	NULL
are	NULL
the	NULL
normal	NULL
counterpart	NULL
of	NULL
these	NULL
transformed	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
data	NULL
presented	NULL
strongly	NULL
support	NULL
a	NULL
role	NULL
for	NULL
this	NULL
transcription	NULL
factor	NULL
in	NULL
B-cell	NULL
differentiation	NULL
and	NULL
perhaps	NULL
in	NULL
B-cell	NULL
transformation	NULL
in	NULL
some	NULL
neoplasias	NULL
.	NULL

©	NULL
1996	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

of	NULL
v-myb	NULL
is	NULL
essential	NULL
for	NULL
and	NULL
correlates	NULL
with	NULL
its	NULL
oncogenic	NULL
ity	NULL
.	NULL
``	NULL

More	NULL
recently	NULL
,	NULL
two	NULL
other	NULL
members	NULL
of	NULL
the	NULL
myb	NULL
family	NULL
,	NULL
called	NULL
A-myb	NULL
and	NULL
B-myb	NULL
,	NULL
have	NULL
been	NULL
cloned	NULL
from	NULL
human	NULL
sources	NULL
through	NULL
their	NULL
homology	NULL
to	NULL
c-myb	NULL
.	NULL
'	NULL

Regions	NULL
of	NULL
homology	NULL
include	NULL
the	NULL
DNA	NULL
binding	NULL
domain	NULL
of	NULL
c-myb	NULL
and	NULL
two	NULL
other	NULL
domains	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
.	NULL
'	NULL

''	NULL
The	NULL
A-myb	NULL
protein	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
recognize	NULL
the	NULL
same	NULL
DNA	NULL
sequence	NULL
as	NULL
c-myb	NULL
,	NULL
but	NULL
its	NULL
transcriptional	NULL
activity	NULL
in	NULL
vitro	NULL
is	NULL
6-	NULL
to	NULL
10-fold	NULL
stronger	NULL
than	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
comparable	NULL
with	NULL
that	NULL
of	NULL
the	NULL
v-myb	NULL
oncogene	NULL
.	NULL
``	NULL

Whereas	NULL
B-myb	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
proliferation	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
,	NULL
``	NULL
little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
biologic	NULL
function	NULL
of	NULL
A-myb	NULL
.	NULL

Its	NULL
expression	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
proliferation	NULL
in	NULL
mature	NULL
leukocytes	NULL
stimulated	NULL
in	NULL
vitro	NULL
,	NULL
unlike	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
.	NULL
``	NULL

A-myb	NULL
was	NULL
found	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
a	NULL
subset	NULL
of	NULL
human	NULL
tonsillar	NULL
B	NULL
lymphocytes	NULL
but	NULL
was	NULL
not	NULL
detected	NULL
at	NULL
significant	NULL
levels	NULL
in	NULL
most	NULL
other	NULL
peripheral	NULL
mature	NULL
leukocyte	NULL
populations	NULL
tested	NULL
(	NULL
monocytes	NULL
,	NULL
neutrophils	NULL
,	NULL
B	NULL
lymphocytes	NULL
)	NULL
at	NULL
rest	NULL
or	NULL
after	NULL
in	NULL
vitro	NULL
stimula-tion	NULL
.	NULL
``	NULL

''	NULL
Only	NULL
resting	NULL
T	NULL
cells	NULL
expressed	NULL
A-myb	NULL
relatively	NULL
weakly	NULL
,	NULL
and	NULL
this	NULL
expression	NULL
was	NULL
lost	NULL
upon	NULL
mitogenic	NULL
stimula-tion	NULL
.	NULL
``	NULL

''	NULL
The	NULL
phenotype	NULL
of	NULL
the	NULL
tonsillar	NULL
B	NULL
cells	NULL
expressing	NULL
higher	NULL
levels	NULL
of	NULL
A-myb	NULL
was	NULL
determined	NULL
by	NULL
analysis	NULL
of	NULL
fluo-rescence-activated	NULL
cell	NULL
sorter	NULL
(	NULL
FACS	NULL
)	NULL
sorted	NULL
cells	NULL
.	NULL

A-myb	NULL
expression	NULL
could	NULL
be	NULL
shown	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
phenotype	NULL
CD38*	NULL
,	NULL
CD39~	NULL
,	NULL
or	NULL
sIgM~	NULL
.	NULL

*	NULL
In	NULL
addition	NULL
,	NULL
the	NULL
CD38	NULL
*	NULL
subpop-ulation	NULL
that	NULL
expressed	NULL
highest	NULL
levels	NULL
of	NULL
A-myb	NULL
was	NULL
found	NULL
to	NULL
be	NULL
highly	NULL
proliferating	NULL
,	NULL
with	NULL
over	NULL
95	NULL
%	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
cycle	NULL
(	NULL
G1	NULL
,	NULL
$	NULL
,	NULL
G2/M	NULL
)	NULL
.	NULL

``	NULL
°	NULL
Both	NULL
the	NULL
phenotype	NULL
and	NULL
cell-cycle	NULL
status	NULL
of	NULL
the	NULL
B	NULL
cells	NULL
expressing	NULL
high	NULL
levels	NULL
of	NULL
A-myb	NULL
suggest	NULL
that	NULL
A-myb	NULL
is	NULL
induced	NULL
during	NULL
B-cell	NULL
activation	NULL
within	NULL
germinal	NULL
centers	NULL
.	NULL

This	NULL
has	NULL
been	NULL
confirmed	NULL
by	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL
``	NULL

'	NULL
This	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
in	NULL
view	NULL
of	NULL
the	NULL
fact	NULL
that	NULL
germinal	NULL
center	NULL
B	NULL
lymphocytes	NULL
undergo	NULL
a	NULL
series	NULL
of	NULL
crucial	NULL
prolifera-	NULL
Blood	NULL
,	NULL
Vol	NULL
87	NULL
,	NULL
No	NULL
5	NULL
(	NULL
March	NULL
1	NULL
}	NULL
,	NULL
1996	NULL
;	NULL
pp	NULL
1900-1911	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
tive	NULL
and	NULL
differentiative	NULL
events	NULL
:	NULL
they	NULL
proliferate	NULL
at	NULL
an	NULL
extremely	NULL
high	NULL
rate	NULL
,	NULL
undergo	NULL
Ig	NULL
class	NULL
switching	NULL
,	NULL
affinity	NULL
matu-ration	NULL
,	NULL
differentiation	NULL
to	NULL
preplasma	NULL
cells	NULL
and	NULL
apoptosis	NULL
.	NULL
``	NULL

A-myb	NULL
was	NULL
recently	NULL
found	NULL
to	NULL
be	NULL
a	NULL
strong	NULL
transcriptional	NULL
activator	NULL
and	NULL
is	NULL
highly	NULL
related	NULL
in	NULL
its	NULL
structure	NULL
and	NULL
biochemical	NULL
activity	NULL
to	NULL
c-myb	NULL
and	NULL
v-myb	NULL
,	NULL
*	NULL
``	NULL
``	NULL
which	NULL
are	NULL
genes	NULL
known	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
hematopoietic	NULL
proliferation/	NULL
differentiation	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
attractive	NULL
to	NULL
hypothesize	NULL
that	NULL
A-myb	NULL
plays	NULL
a	NULL
role	NULL
in	NULL
one	NULL
of	NULL
the	NULL
proliferative/differentiative	NULL
processes	NULL
taking	NULL
place	NULL
within	NULL
germinal	NULL
center	NULL
B	NULL
lymphocytes	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
restricted	NULL
A-myb	NULL
expression	NULL
during	NULL
normal	NULL
B-cell	NULL
differentiation	NULL
``	NULL
is	NULL
maintained	NULL
also	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
investigate	NULL
what	NULL
was	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
A-myb	NULL
gene	NULL
in	NULL
a	NULL
large	NULL
panel	NULL
of	NULL
B-cell	NULL
lines	NULL
and	NULL
fresh	NULL
leukemic	NULL
B-cell	NULL
samples	NULL
,	NULL
which	NULL
represent	NULL
B	NULL
cells	NULL
blocked	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
differentia-tion	NULL
,	NULL
from	NULL
pre-B	NULL
cells	NULL
to	NULL
plasma	NULL
cells	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
have	NULL
determined	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
c-myb	NULL
and	NULL
B-myb	NULL
genes	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
.	NULL

Although	NULL
alterations	NULL
of	NULL
the	NULL
c-myb	NULL
gene	NULL
have	NULL
been	NULL
reported	NULL
in	NULL
murine	NULL
leukemias*	NULL
``	NULL
``	NULL
``	NULL
and	NULL
occasionally	NULL
in	NULL
human	NULL
leukemias	NULL
,	NULL
``	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
thought	NULL
to	NULL
decrease	NULL
during	NULL
hematopoietic	NULL
differentia-tion	NULL
,	NULL
``	NULL
*	NULL
``	NULL
``	NULL
expression	NULL
of	NULL
c-myb	NULL
has	NULL
never	NULL
been	NULL
systematically	NULL
investigated	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
B-myb	NULL
is	NULL
also	NULL
completely	NULL
unknown	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
A-myb	NULL
is	NULL
strongly	NULL
expressed	NULL
in	NULL
the	NULL
majority	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
and	NULL
sIg*t	NULL
B-acute	NULL
lymphoblastic	NULL
leukemia	NULL
(	NULL
B-ALL	NULL
)	NULL
,	NULL
as	NULL
well	NULL
as	NULL
in	NULL
approximately	NULL
25	NULL
%	NULL
of	NULL
B-chronic	NULL
lymphocytic	NULL
leukemia	NULL
(	NULL
B-CLL	NULL
)	NULL
cells	NULL
but	NULL
not	NULL
or	NULL
very	NULL
weakly	NULL
in	NULL
other	NULL
neoplastic	NULL
B	NULL
cells	NULL
studied	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
c-myb	NULL
and	NULL
B-myb	NULL
were	NULL
expressed	NULL
in	NULL
all	NULL
mitotically	NULL
active	NULL
populations	NULL
of	NULL
neoplastic	NULL
B	NULL
cells	NULL
,	NULL
although	NULL
in	NULL
a	NULL
heterogeneous	NULL
manner	NULL
within	NULL
each	NULL
group	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
lines	NULL
and	NULL
cell	NULL
cultures	NULL
.	NULL

The	NULL
Chep	NULL
and	NULL
Eli	NULL
BL	NULL
lines	NULL
and	NULL
Epstein-Barr	NULL
virus-immortalized	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
(	NULL
EBV-LCL	NULL
)	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
A.	NULL
Rickinson	NULL
(	NULL
CRC	NULL
Laboratories	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL
``	NULL

Several	NULL
lines	NULL
(	NULL
Silti	NULL
,	NULL
DN-90	NULL
,	NULL
Cap	NULL
,	NULL
Capo	NULL
)	NULL
were	NULL
established	NULL
by	NULL
A.R	NULL
.	NULL

Silti	NULL
was	NULL
derived	NULL
from	NULL
a	NULL
BL	NULL
patient	NULL
and	NULL
carries	NULL
a	NULL
t	NULL
(	NULL
2	NULL
;	NULL
8	NULL
)	NULL
(	NULL
p11	NULL
;	NULL
q24	NULL
)	NULL
translocation	NULL
.	NULL

DN9O	NULL
was	NULL
established	NULL
from	NULL
a	NULL
BL	NULL
patient	NULL
and	NULL
carries	NULL
a	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
(	NULL
q24	NULL
;	NULL
q32	NULL
)	NULL
translocation	NULL
.	NULL

Cap	NULL
is	NULL
a	NULL
plasmablastic	NULL
leukemia	NULL
cell	NULL
line	NULL
.	NULL

The	NULL
OCI-LY	NULL
cell	NULL
lines	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
Messner	NULL
(	NULL
Ontario	NULL
Cancer	NULL
Institute	NULL
,	NULL
University	NULL
of	NULL
Toronto	NULL
,	NULL
Canada	NULL
)	NULL
.	NULL
``	NULL

OCI-LY3	NULL
has	NULL
been	NULL
described	NULL
as	NULL
a	NULL
diffuse	NULL
large	NULL
cell	NULL
lymphoma	NULL
and	NULL
OCI-LY	NULL
4,8	NULL
and	NULL
10	NULL
as	NULL
immu-noblastic	NULL
lymphomas	NULL
.	NULL
``	NULL

The	NULL
other	NULL
lines	NULL
were	NULL
obtained	NULL
from	NULL
the	NULL
American	NULL
Tissue	NULL
Culture	NULL
Collection	NULL
(	NULL
ATCC	NULL
;	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

All	NULL
lines	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Seromed	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
(	NULL
FCS	NULL
;	NULL
Hyclone	NULL
,	NULL
Steril	NULL
System	NULL
,	NULL
Logan	NULL
,	NULL
UT	NULL
)	NULL
,	NULL
glutamine	NULL
(	NULL
GIBCO	NULL
,	NULL
Paisley	NULL
,	NULL
Scotland	NULL
)	NULL
,	NULL
and	NULL
50	NULL
g/mL	NULL
.	NULL

gentamicin	NULL
(	NULL
GIBCO	NULL
)	NULL
.	NULL

The	NULL
IM-9	NULL
line	NULL
was	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
complete	NULL
A-myb	NULL
cDNA	NULL
cloned	NULL
in	NULL
the	NULL
pCEP4/	NULL
#	NULL
vector	NULL
(	NULL
Invitrogen	NULL
,	NULL
Leek	NULL
,	NULL
Holland	NULL
)	NULL
by	NULL
electroporation	NULL
at	NULL
300	NULL
mV	NULL
,	NULL
960	NULL
uFD	NULL
(	NULL
Gene	NULL
Pulser	NULL
;	NULL
BioRad	NULL
,	NULL
Her-cules	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

Transfectants	NULL
were	NULL
selected	NULL
in	NULL
medium	NULL
containing	NULL
350	NULL
pg/mL	NULL
hygromycin	NULL
(	NULL
Boehringer	NULL
,	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Fresh	NULL
leukemic	NULL
samples	NULL
.	NULL

-	NULL
Bone	NULL
marrow	NULL
(	NULL
BM	NULL
)	NULL
,	NULL
peripheral	NULL
blood	NULL
(	NULL
PB	NULL
)	NULL
,	NULL
or	NULL
lymph	NULL
node	NULL
samples	NULL
were	NULL
obtained	NULL
with	NULL
prior	NULL
informed	NULL
consent	NULL
from	NULL
patients	NULL
with	NULL
ALL	NULL
,	NULL
B-CLL	NULL
,	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
1901	NULL
(	NULL
NHL	NULL
)	NULL
,	NULL
or	NULL
acute	NULL
plasmablastic	NULL
leukemias	NULL
.	NULL

The	NULL
diagnoses	NULL
were	NULL
made	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
and	NULL
French-American-British	NULL
(	NULL
FAB	NULL
)	NULL
classification	NULL
.	NULL

Richter	NULL
's	NULL
syndrome	NULL
patient	NULL
AV	NULL
had	NULL
been	NULL
diagnosed	NULL
to	NULL
have	NULL
CLL	NULL
,	NULL
Rai	NULL
stage	NULL
I	NULL
in	NULL
1987	NULL
.	NULL

The	NULL
white	NULL
blood	NULL
cell	NULL
(	NULL
WBC	NULL
)	NULL
count	NULL
at	NULL
diagnosis	NULL
was	NULL
27	NULL
%	NULL
10°/L	NULL
and	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
was	NULL
A*	NULL
,	NULL
CD5*	NULL
.	NULL

The	NULL
patient	NULL
did	NULL
not	NULL
require	NULL
therapy	NULL
until	NULL
1991	NULL
,	NULL
when	NULL
combined	NULL
chlorambucil/prednisone	NULL
treatment	NULL
was	NULL
initiated	NULL
.	NULL

In	NULL
May	NULL
1992	NULL
,	NULL
AV	NULL
presented	NULL
with	NULL
a	NULL
blastic	NULL
progression	NULL
typical	NULL
of	NULL
Richter	NULL
's	NULL
syndrome	NULL
with	NULL
massive	NULL
lymphadenopathies	NULL
and	NULL
hepatomegaly	NULL
.	NULL

Biopsy	NULL
of	NULL
an	NULL
axillary	NULL
lymph	NULL
node	NULL
showed	NULL
the	NULL
presence	NULL
of	NULL
blastic	NULL
lymphoid	NULL
cells	NULL
.	NULL

RS	NULL
was	NULL
documented	NULL
by	NULL
the	NULL
histologic	NULL
analysis	NULL
of	NULL
the	NULL
lymph	NULL
node	NULL
and	NULL
immunophenotype	NULL
of	NULL
the	NULL
blastic	NULL
component	NULL
.	NULL

RNA	NULL
extraction	NULL
and	NULL
Northern	NULL
blots	NULL
.	NULL

-	NULL
RNA	NULL
was	NULL
extracted	NULL
by	NULL
standard	NULL
guanidium	NULL
isothiocyanate	NULL
and	NULL
cesium	NULL
chloride	NULL
gradient	NULL
purifi-cation	NULL
.	NULL

``	NULL
*	NULL
Twenty	NULL
micrograms	NULL
of	NULL
total	NULL
RNA	NULL
was	NULL
run	NULL
in	NULL
1	NULL
%	NULL
formalde-hyde-agarose	NULL
gels	NULL
.	NULL

The	NULL
A-myb	NULL
,	NULL
c-myb	NULL
,	NULL
B-myb	NULL
,	NULL
and	NULL
S-actin	NULL
probes	NULL
have	NULL
been	NULL
described	NULL
previously	NULL
``	NULL
and	NULL
were	NULL
labeled	NULL
with	NULL
P	NULL
by	NULL
standard	NULL
nick-translation	NULL
.	NULL

The	NULL
c-myb	NULL
probe	NULL
contained	NULL
the	NULL
third	NULL
exon	NULL
of	NULL
human	NULL
c-myb	NULL
from	NULL
Cla	NULL
I	NULL
to	NULL
EcoRI	NULL
(	NULL
myc3RC	NULL
)	NULL
.	NULL
``	NULL

Western	NULL
blots	NULL
.	NULL

-	NULL
The	NULL
A-myb	NULL
specific	NULL
antiserum	NULL
was	NULL
raised	NULL
in	NULL
rabbits	NULL
against	NULL
a	NULL
nonconserved	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
A-myb	NULL
protein	NULL
produced	NULL
in	NULL
bacteria	NULL
(	NULL
a	NULL
fragment	NULL
from	NULL
amino	NULL
acid	NULL
218	NULL
to	NULL
482	NULL
showing	NULL
19	NULL
%	NULL
and	NULL
21	NULL
%	NULL
identity	NULL
of	NULL
amino-acids	NULL
with	NULL
c-myb	NULL
and	NULL
B-myb	NULL
)	NULL
.	NULL

The	NULL
antiserum	NULL
used	NULL
has	NULL
already	NULL
been	NULL
described	NULL
.	NULL
``	NULL

''	NULL
``	NULL
It	NULL
was	NULL
first	NULL
purified	NULL
by	NULL
adsorption	NULL
onto	NULL
A-myb	NULL
free	NULL
bacterial	NULL
lysates®	NULL
and	NULL
its	NULL
specificity	NULL
tested	NULL
in	NULL
Western	NULL
blots	NULL
containing	NULL
either	NULL
bacterially	NULL
expressed	NULL
A-myb	NULL
or	NULL
in	NULL
fibroblasts	NULL
transiently	NULL
transfected	NULL
with	NULL
the	NULL
A-myb	NULL
complete	NULL
or	NULL
truncated	NULL
cDNA	NULL
or	NULL
with	NULL
the	NULL
c-myb	NULL
cDNA	NULL
(	NULL
and	NULL
unpublished	NULL
data	NULL
,	NULL
November	NULL
1992	NULL
)	NULL
.	NULL

B	NULL
cells	NULL
,	NULL
2	NULL
x	NULL
10°	NULL
,	NULL
were	NULL
lysed	NULL
in	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
loading	NULL
buffer	NULL
and	NULL
run	NULL
in	NULL
a	NULL
10	NULL
%	NULL
SDS/poly-acrylamide	NULL
gel	NULL
.	NULL

The	NULL
gels	NULL
were	NULL
electroblotted	NULL
onto	NULL
nitrocellulose	NULL
filters	NULL
(	NULL
Schleicher	NULL
and	NULL
Schuell	NULL
,	NULL
Dassel	NULL
,	NULL
Germany	NULL
)	NULL
for	NULL
8	NULL
hours	NULL
at	NULL
35	NULL
V	NULL
,	NULL
according	NULL
to	NULL
standard	NULL
procedures	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
incubated	NULL
first	NULL
in	NULL
blocking	NULL
solution	NULL
(	NULL
phosphate-buffered	NULL
saline	NULL
[	NULL
PBS	NULL
]	NULL
containing	NULL
5	NULL
%	NULL
nonfat	NULL
milk	NULL
powder	NULL
)	NULL
overnight	NULL
,	NULL
then	NULL
with	NULL
the	NULL
rabbit	NULL
antiserum	NULL
(	NULL
1/	NULL
1,000	NULL
in	NULL
blocking	NULL
buffer	NULL
)	NULL
for	NULL
1	NULL
hour	NULL
and	NULL
finally	NULL
in	NULL
diluted	NULL
donkey-antirabbit	NULL
conjugated	NULL
to	NULL
horseradish	NULL
peroxidase	NULL
(	NULL
1/1,000	NULL
;	NULL
Amersham	NULL
,	NULL
Little	NULL
Chalfont	NULL
,	NULL
Buckinghamshire	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Between	NULL
each	NULL
incubation	NULL
the	NULL
blots	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
for	NULL
10	NULL
minutes	NULL
in	NULL
PBS	NULL
containing	NULL
0.5	NULL
%	NULL
NP4O	NULL
.	NULL

Detection	NULL
was	NULL
performed	NULL
using	NULL
the	NULL
ECL	NULL
chemilumines-cence	NULL
system	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

Densitometry	NULL
of	NULL
Northern	NULL
blots	NULL
.	NULL

The	NULL
A-myb	NULL
hybridization	NULL
signals	NULL
from	NULL
selected	NULL
blots	NULL
were	NULL
scanned	NULL
with	NULL
a	NULL
GS300	NULL
Scanning	NULL
Densitometer	NULL
(	NULL
Hoefer	NULL
Scientific	NULL
Instruments	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
using	NULL
the	NULL
GS370	NULL
,	NULL
version	NULL
2.0	NULL
program	NULL
run	NULL
on	NULL
a	NULL
MacIntosh	NULL
Plus	NULL
computer	NULL
(	NULL
Apple	NULL
Computer	NULL
,	NULL
Inc	NULL
,	NULL
Cupertino	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
ethidium	NULL
bromide-stained	NULL
288	NULL
RNA	NULL
content	NULL
of	NULL
each	NULL
lane	NULL
was	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
on	NULL
an	NULL
image	NULL
analyzer	NULL
(	NULL
IBAS	NULL
2.0	NULL
software	NULL
)	NULL
(	NULL
Kontron/	NULL
Zeiss	NULL
,	NULL
Oberkochen	NULL
,	NULL
Germany	NULL
)	NULL
running	NULL
under	NULL
MS-DOS	NULL
environment	NULL
(	NULL
PC	NULL
80286	NULL
processor	NULL
)	NULL
.	NULL

The	NULL
signals	NULL
from	NULL
different	NULL
blots	NULL
were	NULL
normalized	NULL
for	NULL
(	NULL
288	NULL
)	NULL
RNA	NULL
content	NULL
and	NULL
reference	NULL
RNA	NULL
(	NULL
ie	NULL
,	NULL
an	NULL
identical	NULL
positive	NULL
RNA	NULL
,	NULL
usually	NULL
RNA	NULL
from	NULL
buoyant	NULL
tonsillar	NULL
B	NULL
cells	NULL
or	NULL
a	NULL
BL	NULL
line	NULL
,	NULL
present	NULL
in	NULL
the	NULL
different	NULL
blots	NULL
)	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
and	NULL
cell	NULL
sorting	NULL
.	NULL

-	NULL
The	NULL
CD3	NULL
,	NULL
CD20	NULL
,	NULL
CD5	NULL
,	NULL
and	NULL
anti-	NULL
«	NULL
and	NULL
A	NULL
antibodies	NULL
were	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Mountain	NULL
View	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

The	NULL
HD	NULL
50	NULL
(	NULL
CD23	NULL
)	NULL
antibody	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
G.	NULL
Moldenhauer	NULL
(	NULL
Deutsches	NULL
Krebsforschungszentrum	NULL
,	NULL
Heidelberg	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Monoclonal	NULL
antibody	NULL
(	NULL
MoAb	NULL
)	NULL
AC2	NULL
(	NULL
CD39	NULL
)	NULL
was	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Dr	NULL
A.	NULL
Rowe	NULL
(	NULL
CRC	NULL
laboratories	NULL
,	NULL
University	NULL
of	NULL
Birmingham	NULL
,	NULL
Birmingham	NULL
,	NULL
UK	NULL
)	NULL
.	NULL

Antibody	NULL
38.13	NULL
(	NULL
CD77	NULL
)	NULL
was	NULL
kindly	NULL
sent	NULL
by	NULL
Prof	NULL
T.	NULL
Tursz	NULL
(	NULL
Institut	NULL
Gustave-Roussy	NULL
,	NULL
Villejuif	NULL
,	NULL
France	NULL
)	NULL
.	NULL

MoAbs	NULL
BerH2	NULL
(	NULL
CD30	NULL
)	NULL
and	NULL
Ki-24	NULL
(	NULL
CD70	NULL
)	NULL
were	NULL
a	NULL
generous	NULL
gift	NULL
of	NULL
Dr	NULL
H.	NULL
Stein	NULL
(	NULL
Institute	NULL
of	NULL
Pathology	NULL
,	NULL
University	NULL
of	NULL
Berlin	NULL
,	NULL
Berlin	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
stained	NULL
by	NULL
standard	NULL
indirect	NULL
immunofluorescence	NULL
procedures	NULL
using	NULL
a	NULL
fluorescein-labeled	NULL
goat-antimouse	NULL
anti	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1902	NULL
pre-B	NULL
_EBV-LCL_	NULL
B-lymphomas	NULL
B	NULL
q	NULL
2a	NULL
4	NULL
2	NULL
30°	NULL
400	NULL
10	NULL
2	NULL
3	NULL
400	NULL
d	NULL
Reits	NULL
body	NULL
(	NULL
Technogenetics	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
.	NULL

Analysis	NULL
and	NULL
cell	NULL
sorting	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
FACS	NULL
(	NULL
FACS	NULL
Star	NULL
Plus	NULL
,	NULL
Becton	NULL
Dickinson	NULL
,	NULL
Sun-nyvale	NULL
,	NULL
CA	NULL
)	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Semi-quantitative	NULL
polymerase	NULL
chain	NULL
reaction	NULL
(	NULL
PCR	NULL
)	NULL
analysis	NULL
.	NULL

Total	NULL
RNA	NULL
from	NULL
cell	NULL
populations	NULL
sorted	NULL
on	NULL
the	NULL
FACS	NULL
was	NULL
purified	NULL
on	NULL
a	NULL
standard	NULL
isothiocyanate/cesium	NULL
chloride	NULL
gradient	NULL
.	NULL

Six	NULL
or	NULL
25	NULL
ng	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
reverse	NULL
transcribed	NULL
(	NULL
RT	NULL
)	NULL
in	NULL
20	NULL
LL	NULL
.	NULL

Three	NULL
microliters	NULL
of	NULL
RT	NULL
product	NULL
was	NULL
amplified	NULL
in	NULL
duplicate	NULL
for	NULL
20	NULL
and	NULL
25	NULL
cycles	NULL
with	NULL
B-actin	NULL
and	NULL
A-myb	NULL
specific	NULL
primers	NULL
,	NULL
respectively	NULL
,	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Ten	NULL
microliters	NULL
of	NULL
amplification	NULL
product	NULL
was	NULL
run	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
onto	NULL
nitrocellulose	NULL
and	NULL
hybridized	NULL
with	NULL
P-labeled	NULL
3-actin	NULL
and	NULL
A-myb	NULL
specific	NULL
probes	NULL
,	NULL
respectively	NULL
.	NULL

The	NULL
data	NULL
were	NULL
quantified	NULL
on	NULL
the	NULL
GS300	NULL
scanning	NULL
densitometer	NULL
(	NULL
Hoefer	NULL
Scientific	NULL
Instru-ments	NULL
)	NULL
.	NULL

RESULTS	NULL
Expression	NULL
of	NULL
A-myb	NULL
in	NULL
a	NULL
panel	NULL
of	NULL
B-cell	NULL
lines	NULL
.	NULL

In	NULL
a	NULL
previous	NULL
study	NULL
,	NULL
we	NULL
had	NULL
found	NULL
that	NULL
normal	NULL
highly	NULL
proliferating	NULL
tonsillar	NULL
B	NULL
lymphocytes	NULL
with	NULL
the	NULL
phenotype	NULL
CD38	NULL
,	NULL
CD39~	NULL
,	NULL
sIgM~	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
A-myb	NULL
.	NULL
``	NULL

''	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
A-myb	NULL
,	NULL
unlike	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
was	NULL
not	NULL
induced	NULL
during	NULL
proliferation	NULL
of	NULL
tonsillar	NULL
B	NULL
cells	NULL
in	NULL
vitro	NULL
induced	NULL
by	NULL
several	NULL
polyclonal	NULL
B-cell	NULL
activators	NULL
,	NULL
suggesting	NULL
that	NULL
expression	NULL
of	NULL
A-myb	NULL
was	NULL
specific	NULL
for	NULL
a	NULL
particular	NULL
differentiation	NULL
stage	NULL
of	NULL
B	NULL
cells	NULL
or	NULL
for	NULL
in	NULL
vivo-	NULL
but	NULL
not	NULL
in	NULL
vitro-induced	NULL
proliferation	NULL
.	NULL

'*	NULL
``	NULL
``	NULL
Therefore	NULL
,	NULL
we	NULL
set	NULL
out	NULL
to	NULL
investigate	NULL
the	NULL
pattern	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
tested	NULL
A-myb	NULL
RNA	NULL
expression	NULL
in	NULL
a	NULL
panel	NULL
of	NULL
B-cell	NULL
lines	NULL
,	NULL
including	NULL
2	NULL
pre-B	NULL
lines	NULL
,	NULL
6	NULL
EBV-LCL	NULL
,	NULL
4	NULL
NHL	NULL
,	NULL
6	NULL
myelomas	NULL
,	NULL
and	NULL
14	NULL
BL	NULL
lines	NULL
representing	NULL
the	NULL
whole	NULL
spectrum	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

A-myb	NULL
was	NULL
very	NULL
weak	NULL
or	NULL
negative	NULL
in	NULL
all	NULL
18	NULL
non-BL	NULL
lines	NULL
,	NULL
but	NULL
was	NULL
very	NULL
highly	NULL
expressed	NULL
in	NULL
two	NULL
thirds	NULL
of	NULL
the	NULL
BL	NULL
cell	NULL
lines	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
:	NULL
9	NULL
of	NULL
14	NULL
BL	NULL
lines	NULL
(	NULL
64	NULL
%	NULL
)	NULL
showed	NULL
very	NULL
high	NULL
A-myb	NULL
expression	NULL
,	NULL
1	NULL
(	NULL
7	NULL
%	NULL
)	NULL
(	NULL
DN90	NULL
;	NULL
lane	NULL
12	NULL
)	NULL
expressed	NULL
intermediate	NULL
levels	NULL
of	NULL
A-myb	NULL
,	NULL
and	NULL
4	NULL
were	NULL
weak	NULL
or	NULL
negative	NULL
(	NULL
29	NULL
%	NULL
)	NULL
(	NULL
ST486	NULL
,	NULL
Pollik	NULL
,	NULL
Namalwa	NULL
,	NULL
JD38	NULL
,	NULL
lanes	NULL
3	NULL
,	NULL
6	NULL
,	NULL
10	NULL
,	NULL
and	NULL
11	NULL
,	NULL
respectively	NULL
,	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

In	NULL
several	NULL
blots	NULL
,	NULL
RNA	NULL
from	NULL
normal	NULL
buoyant	NULL
tonsillar	NULL
B	NULL
cells	NULL
was	NULL
used	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
(	NULL
lanes	NULL
“	NULL
my	NULL
``	NULL
_	NULL
'	NULL
;	NULL
e	NULL
's	NULL
igi	NULL
r	NULL
wis	NULL
cess	NULL
GOLAY	NULL
ET	NULL
AL	NULL
Myelomas	NULL
3	NULL
-	NULL
40	NULL
50	NULL
6	NULL
|	NULL
Fig	NULL
1	NULL
.	NULL

-	NULL
Myb	NULL
mRNA	NULL
expression	NULL
‘	NULL
A-Myb	NULL
_	NULL
in	NULL
human	NULL
B-cell	NULL
lines	NULL
.	NULL

RNA	NULL
was	NULL
|	NULL
extracted	NULL
from	NULL
a	NULL
panel	NULL
of	NULL
B-cell	NULL
|	NULL
}	NULL
lines	NULL
_	NULL
representing	NULL
_	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Lane	NULL
B	NULL
,	NULL
control	NULL
RNA	NULL
from	NULL
normal	NULL
tonsillar	NULL
buoyant	NULL
B	NULL
cells	NULL
;	NULL
pre-B	NULL
ALL	NULL
:	NULL
697	NULL
(	NULL
1	NULL
)	NULL
,	NULL
Nalm	NULL
6	NULL
(	NULL
2	NULL
)	NULL
;	NULL
EBV-LCL	NULL
:	NULL
PCK3	NULL
(	NULL
1	NULL
)	NULL
,	NULL
CESS	NULL
(	NULL
2	NULL
)	NULL
,	NULL
Laz156	NULL
(	NULL
3	NULL
)	NULL
,	NULL
Capo	NULL
(	NULL
4	NULL
)	NULL
;	NULL
B	NULL
lymphomas	NULL
:	NULL
OCI-LY3	NULL
(	NULL
1	NULL
)	NULL
,	NULL
OCI-LY4	NULL
(	NULL
2	NULL
)	NULL
,	NULL
OCI-LY8	NULL
(	NULL
3	NULL
)	NULL
,	NULL
OCI-LY10	NULL
(	NULL
4	NULL
)	NULL
;	NULL
myelomas	NULL
:	NULL
Hand	NULL
(	NULL
1	NULL
)	NULL
,	NULL
CBI.3	NULL
(	NULL
2	NULL
)	NULL
,	NULL
Grafstein	NULL
(	NULL
3	NULL
)	NULL
,	NULL
RPMI	NULL
8226	NULL
(	NULL
4	NULL
)	NULL
,	NULL
IM-9	NULL
(	NULL
5	NULL
)	NULL
,	NULL
and	NULL
Cap	NULL
(	NULL
6	NULL
)	NULL
.	NULL

The	NULL
same	NULL
blots	NULL
were	NULL
hybridized	NULL
successively	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

The	NULL
photographs	NULL
of	NULL
the	NULL
ethidium	NULL
stained	NULL
blots	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

we	NULL
nD	NULL
B-myb	NULL
$	NULL
B-actin	NULL
B	NULL
of	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
different	NULL
cell	NULL
lines	NULL
was	NULL
stable	NULL
over	NULL
an	NULL
extended	NULL
time	NULL
of	NULL
culture	NULL
and	NULL
thus	NULL
did	NULL
not	NULL
reflect	NULL
a	NULL
particular	NULL
state	NULL
of	NULL
the	NULL
cells	NULL
or	NULL
the	NULL
growth	NULL
conditions	NULL
,	NULL
but	NULL
rather	NULL
was	NULL
characteristic	NULL
of	NULL
the	NULL
cell	NULL
lines	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
further	NULL
demonstrate	NULL
the	NULL
specific	NULL
expression	NULL
of	NULL
A-myb	NULL
in	NULL
BL	NULL
rather	NULL
than	NULL
EBV-LCL	NULL
,	NULL
we	NULL
have	NULL
also	NULL
tested	NULL
pairs	NULL
of	NULL
BL	NULL
and	NULL
EBV-LCL	NULL
,	NULL
both	NULL
EBV	NULL
*	NULL
and	NULL
originating	NULL
from	NULL
the	NULL
same	NULL
patients	NULL
(	NULL
Eli	NULL
and	NULL
Chep	NULL
)	NULL
.	NULL
``	NULL

''	NULL
As	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
,	NULL
A-myb	NULL
is	NULL
specifically	NULL
and	NULL
strongly	NULL
expressed	NULL
in	NULL
the	NULL
BL	NULL
but	NULL
not	NULL
EBV-LCL	NULL
lines	NULL
from	NULL
both	NULL
of	NULL
these	NULL
patients	NULL
.	NULL

Of	NULL
note	NULL
is	NULL
that	NULL
in	NULL
all	NULL
cases	NULL
,	NULL
the	NULL
size	NULL
of	NULL
the	NULL
major	NULL
A-myb	NULL
transcript	NULL
(	NULL
about	NULL
5	NULL
kb	NULL
)	NULL
appeared	NULL
identical	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
normal	NULL
tonsillar	NULL
B	NULL
lymphocytes	NULL
run	NULL
in	NULL
parallel	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
,	NULL
a	NULL
weaker	NULL
band	NULL
of	NULL
about	NULL
10	NULL
kb	NULL
is	NULL
observed	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
of	NULL
gross	NULL
structural	NULL
abnormality	NULL
of	NULL
A-myb	NULL
in	NULL
these	NULL
human	NULL
neoplasms	NULL
as	NULL
detected	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

Both	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
show	NULL
the	NULL
results	NULL
of	NULL
hybridization	NULL
with	NULL
the	NULL
3-actin	NULL
probe	NULL
and	NULL
the	NULL
photographs	NULL
of	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
gels	NULL
demonstrate	NULL
that	NULL
all	NULL
lanes	NULL
contained	NULL
comparable	NULL
amounts	NULL
of	NULL
RNA	NULL
.	NULL

To	NULL
accurately	NULL
quantify	NULL
A-myb	NULL
expression	NULL
,	NULL
we	NULL
selected	NULL
those	NULL
blots	NULL
that	NULL
contained	NULL
an	NULL
identical	NULL
RNA	NULL
sample	NULL
(	NULL
RNA	NULL
from	NULL
buoyant	NULL
tonsillar	NULL
B	NULL
cells	NULL
,	NULL
ie	NULL
,	NULL
a	NULL
reference	NULL
RNA	NULL
)	NULL
that	NULL
could	NULL
be	NULL
used	NULL
to	NULL
compare	NULL
the	NULL
hybridization	NULL
signals	NULL
from	NULL
different	NULL
blots	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Quantifica-tion	NULL
of	NULL
25	NULL
of	NULL
the	NULL
32	NULL
cell	NULL
lines	NULL
could	NULL
thus	NULL
be	NULL
performed	NULL
by	NULL
densitometric	NULL
analysis	NULL
.	NULL

The	NULL
A-myb	NULL
signals	NULL
were	NULL
normalized	NULL
for	NULL
the	NULL
quantity	NULL
of	NULL
total	NULL
RNA	NULL
,	NULL
as	NULL
determined	NULL
by	NULL
densitometric	NULL
analysis	NULL
of	NULL
the	NULL
28S	NULL
RNA	NULL
,	NULL
and	NULL
the	NULL
data	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

The	NULL
data	NULL
clearly	NULL
show	NULL
that	NULL
A-myb	NULL
expression	NULL
in	NULL
most	NULL
BL	NULL
lines	NULL
is	NULL
10-	NULL
to	NULL
100-fold	NULL
stronger	NULL
than	NULL
in	NULL
other	NULL
cell	NULL
lines	NULL
,	NULL
although	NULL
it	NULL
shows	NULL
some	NULL
variability	NULL
between	NULL
cell	NULL
lines	NULL
.	NULL

A-myb	NULL
expression	NULL
in	NULL
all	NULL
the	NULL
other	NULL
lines	NULL
is	NULL
low	NULL
or	NULL
undetectable	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
share	NULL
some	NULL
functional	NULL
and	NULL
structural	NULL
homologies	NULL
with	NULL
A-myb	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
hybridized	NULL
the	NULL
same	NULL
blots	NULL
with	NULL
the	NULL
c-myb	NULL
and	NULL
B-myb	NULL
probes	NULL
.	NULL

Most	NULL
cell	NULL
lines	NULL
of	NULL
all	NULL
neoplastic	NULL
groups	NULL
were	NULL
positive	NULL
for	NULL
both	NULL
c-myb	NULL
and	NULL
B	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
Burkitt	NULL
's	NULL
cell	NULL
lines	NULL
Eli	NULL
_	NULL
8	NULL
4	NULL
5	NULL
6	NULL
7	NULL
3	NULL
Fig	NULL
2	NULL
.	NULL

Myb	NULL
and	NULL
c-myc	NULL
mRNA	NULL
expression	NULL
in	NULL
BL	NULL
lines	NULL
.	NULL

Northern	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
extracted	NULL
from	NULL
the	NULL
following	NULL
BL	NULL
lines	NULL
:	NULL
Ramos	NULL
(	NULL
1	NULL
)	NULL
,	NULL
MC116	NULL
(	NULL
2	NULL
)	NULL
,	NULL
ST486	NULL
(	NULL
3	NULL
)	NULL
,	NULL
BL2	NULL
(	NULL
4	NULL
)	NULL
,	NULL
Daudi	NULL
(	NULL
5	NULL
)	NULL
,	NULL
Pollik	NULL
(	NULL
6	NULL
)	NULL
,	NULL
Silti	NULL
(	NULL
7	NULL
)	NULL
,	NULL
P3HR1	NULL
(	NULL
8	NULL
)	NULL
,	NULL
Raji	NULL
(	NULL
9	NULL
)	NULL
,	NULL
Namalwa	NULL
(	NULL
10	NULL
)	NULL
,	NULL
JD38	NULL
(	NULL
11	NULL
)	NULL
,	NULL
DN90O	NULL
(	NULL
12	NULL
)	NULL
.	NULL

BL	NULL
and	NULL
EBV-LCL	NULL
from	NULL
patients	NULL
Eli	NULL
and	NULL
Chep	NULL
.	NULL

Lane	NULL
B	NULL
,	NULL
control	NULL
RNA	NULL
from	NULL
normal	NULL
tonsillar	NULL
buoyant	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
in	NULL
succession	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

The	NULL
photographs	NULL
of	NULL
the	NULL
ethidium-stained	NULL
blots	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

ND	NULL
,	NULL
not	NULL
done	NULL
.	NULL

myb	NULL
,	NULL
although	NULL
with	NULL
some	NULL
heterogeneity	NULL
within	NULL
each	NULL
group	NULL
(	NULL
Figs	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
A-myb	NULL
expression	NULL
was	NULL
clearly	NULL
different	NULL
and	NULL
more	NULL
restricted	NULL
than	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
.	NULL

Since	NULL
the	NULL
A-myb	NULL
gene	NULL
has	NULL
been	NULL
localized	NULL
on	NULL
chromosome	NULL
8q22-23	NULL
,	NULL
that	NULL
is	NULL
relatively	NULL
close	NULL
to	NULL
c-myc	NULL
(	NULL
8q24	NULL
)	NULL
,	NULL
``	NULL
°	NULL
we	NULL
have	NULL
performed	NULL
Southern	NULL
blot	NULL
analysis	NULL
using	NULL
the	NULL
A-myb	NULL
complete	NULL
cDNA	NULL
as	NULL
probe	NULL
after	NULL
standard	NULL
or	NULL
pulse-field	NULL
gel	NULL
electrophore-	NULL
Cell	NULL
lines	NULL
200	NULL
7	NULL
Relative	NULL
O.D	NULL
.	NULL

units	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
[	NULL
|	NULL
I	NULL
l	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
100	NULL
-	NULL
1	NULL
I	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
I	NULL
|	NULL
I	NULL
|	NULL
I	NULL
I	NULL
|	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
I	NULL
*	NULL
»	NULL
_|	NULL
U	NULL
®	NULL
I	NULL
8	NULL
e	NULL
mane	NULL
!	NULL

Fees	NULL
pre-B	NULL
BL	NULL
EBV-LCL	NULL
myeloma	NULL
lymphoma	NULL
Fig	NULL
3	NULL
.	NULL

Densitometric	NULL
analysis	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

The	NULL
A-myb	NULL
signals	NULL
from	NULL
several	NULL
blots	NULL
containing	NULL
a	NULL
reference	NULL
RNA	NULL
were	NULL
measured	NULL
by	NULL
densitometric	NULL
analysis	NULL
and	NULL
normalized	NULL
for	NULL
both	NULL
total	NULL
RNA	NULL
content	NULL
and	NULL
against	NULL
a	NULL
reference	NULL
RNA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
arbitrary	NULL
optical	NULL
density	NULL
(	NULL
O.D	NULL
.	NULL
)	NULL

units	NULL
.	NULL

1903	NULL
Chep	NULL
_	NULL
9	NULL
10	NULL
11	NULL
12	NULL
BL	NULL
LCL	NULL
BL	NULL
LCL	NULL
B-actin	NULL
188	NULL
sis	NULL
of	NULL
DNA	NULL
from	NULL
several	NULL
BL	NULL
cell	NULL
lines	NULL
,	NULL
including	NULL
cell	NULL
lines	NULL
that	NULL
rearrange	NULL
far	NULL
upstream	NULL
of	NULL
c-mye	NULL
(	NULL
Daudi	NULL
,	NULL
but	NULL
could	NULL
not	NULL
detect	NULL
any	NULL
rearrangement	NULL
of	NULL
A-myb	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

We	NULL
also	NULL
hybridized	NULL
the	NULL
BL	NULL
samples	NULL
with	NULL
a	NULL
c-myc	NULL
probe	NULL
to	NULL
determine	NULL
whether	NULL
A-myb	NULL
levels	NULL
correlate	NULL
with	NULL
those	NULL
of	NULL
c-myc	NULL
.	NULL

The	NULL
results	NULL
shown	NULL
in	NULL
Fig	NULL
2	NULL
demonstrate	NULL
that	NULL
there	NULL
is	NULL
no	NULL
direct	NULL
correlation	NULL
between	NULL
A-myb	NULL
and	NULL
c-myc	NULL
expression	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
.	NULL

For	NULL
example	NULL
,	NULL
one	NULL
line	NULL
negative	NULL
for	NULL
A-myb	NULL
(	NULL
line	NULL
10	NULL
)	NULL
has	NULL
a	NULL
rather	NULL
strong	NULL
c-myc	NULL
signal	NULL
,	NULL
and	NULL
others	NULL
that	NULL
show	NULL
strong	NULL
A-myb	NULL
expression	NULL
(	NULL
lines	NULL
7	NULL
,	NULL
9	NULL
,	NULL
Eli	NULL
)	NULL
have	NULL
relatively	NULL
weak	NULL
c-myc	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
protein	NULL
correlates	NULL
with	NULL
that	NULL
of	NULL
the	NULL
RNA	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
levels	NULL
of	NULL
A-myb	NULL
mRNA	NULL
correlate	NULL
with	NULL
those	NULL
of	NULL
its	NULL
protein	NULL
,	NULL
a	NULL
number	NULL
of	NULL
cell	NULL
lines	NULL
were	NULL
examined	NULL
for	NULL
A-myb	NULL
protein	NULL
expression	NULL
in	NULL
Western	NULL
blots	NULL
with	NULL
our	NULL
purified	NULL
rabbit	NULL
antiserum	NULL
.	NULL

Although	NULL
this	NULL
antiserum	NULL
had	NULL
been	NULL
previously	NULL
characterized	NULL
and	NULL
shown	NULL
to	NULL
specifically	NULL
recognize	NULL
the	NULL
A-myb	NULL
protein	NULL
,	NULL
``	NULL
its	NULL
specificity	NULL
was	NULL
further	NULL
verified	NULL
in	NULL
the	NULL
myeloma	NULL
cell	NULL
line	NULL
IM9	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
complete	NULL
A-myb	NULL
cDNA	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
4A	NULL
and	NULL
as	NULL
observed	NULL
previously	NULL
,	NULL
the	NULL
A-myb	NULL
protein	NULL
runs	NULL
as	NULL
a	NULL
doublet	NULL
of	NULL
about	NULL
90	NULL
kD	NULL
.	NULL
``	NULL

By	NULL
analogy	NULL
with	NULL
c-myb	NULL
,	NULL
the	NULL
doublet	NULL
probably	NULL
represents	NULL
different	NULL
phosphorylation	NULL
forms	NULL
of	NULL
A-myb	NULL
,	NULL
``	NULL
``	NULL
the	NULL
relative	NULL
amounts	NULL
of	NULL
which	NULL
can	NULL
vary	NULL
in	NULL
different	NULL
cells	NULL
(	NULL
Fig	NULL
4A	NULL
and	NULL
J.G	NULL
.	NULL

,	NULL
M.L	NULL
.	NULL

,	NULL
unpublished	NULL
observations	NULL
,	NULL
April	NULL
1993-March	NULL
1994	NULL
)	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
have	NULL
a	NULL
different	NULL
molecular	NULL
weight	NULL
(	NULL
of	NULL
75	NULL
and	NULL
93	NULL
to	NULL
100	NULL
kD	NULL
,	NULL
respectively	NULL
)	NULL
**	NULL
``	NULL
and	NULL
are	NULL
not	NULL
recognized	NULL
by	NULL
the	NULL
antiserum	NULL
that	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
nonconserved	NULL
region	NULL
of	NULL
the	NULL
A-myb	NULL
protein	NULL
.	NULL
``	NULL

We	NULL
next	NULL
tested	NULL
A-myb	NULL
protein	NULL
expression	NULL
in	NULL
selected	NULL
cell	NULL
lines	NULL
:	NULL
these	NULL
were	NULL
4	NULL
BL	NULL
A-myb	NULL
positive	NULL
in	NULL
Northern	NULL
analysis	NULL
,	NULL
3	NULL
BL	NULL
negative	NULL
for	NULL
A-myb	NULL
RNA	NULL
expression	NULL
,	NULL
3	NULL
EBV-LCL	NULL
,	NULL
and	NULL
2	NULL
myelomas	NULL
.	NULL

As	NULL
shown	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1904	NULL
A	NULL
B	NULL
Burkitt	NULL
's	NULL
lymphomas	NULL
GOLAY	NULL
ET	NULL
AL	NULL
A-myb	NULL
positive	NULL
negative	NULL
kd	NULL
Xfire	NULL
C	NULL
EBV-LCL	NULL
__	NULL
Myelomas	NULL
in	NULL
Fig	NULL
2B	NULL
and	NULL
C	NULL
,	NULL
A-myb	NULL
protein	NULL
expression	NULL
paralleled	NULL
that	NULL
of	NULL
its	NULL
RNA	NULL
in	NULL
all	NULL
12	NULL
cell	NULL
lines	NULL
tested	NULL
.	NULL

In	NULL
all	NULL
cases	NULL
the	NULL
protein	NULL
was	NULL
nuclear	NULL
as	NULL
expected	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
both	NULL
the	NULL
protein	NULL
and	NULL
the	NULL
RNA	NULL
of	NULL
A-myb	NULL
are	NULL
highly	NULL
expressed	NULL
in	NULL
most	NULL
BL	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
the	NULL
other	NULL
B-cell	NULL
lines	NULL
tested	NULL
.	NULL

It	NULL
is	NULL
worth	NULL
noting	NULL
that	NULL
,	NULL
although	NULL
the	NULL
size	NULL
of	NULL
the	NULL
protein	NULL
was	NULL
identical	NULL
to	NULL
that	NULL
of	NULL
normal	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
expression	NULL
were	NULL
5	NULL
to	NULL
10	NULL
times	NULL
higher	NULL
in	NULL
BL	NULL
lines	NULL
relative	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
purified	NULL
CD38*	NULL
normal	NULL
B	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
4B	NULL
,	NULL
lane	NULL
B	NULL
)	NULL
.	NULL

Because	NULL
our	NULL
antiserum	NULL
does	NULL
not	NULL
recognize	NULL
the	NULL
native	NULL
protein	NULL
in	NULL
immu-nocytochemistry	NULL
,	NULL
it	NULL
is	NULL
not	NULL
possible	NULL
at	NULL
present	NULL
to	NULL
assess	NULL
the	NULL
proportion	NULL
of	NULL
the	NULL
cells	NULL
in	NULL
either	NULL
BL	NULL
lines	NULL
or	NULL
CD38*	NULL
tonsillar	NULL
B	NULL
cells	NULL
expressing	NULL
the	NULL
A-myb	NULL
protein	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
can	NULL
not	NULL
determine	NULL
whether	NULL
A-myb	NULL
is	NULL
overexpressed	NULL
at	NULL
the	NULL
single	NULL
cell	NULL
level	NULL
.	NULL

The	NULL
pattern	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
BL	NULL
cell	NULL
lines	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
presence	NULL
of	NULL
EBV	NULL
,	NULL
the	NULL
type	NULL
of	NULL
chromosomal	NULL
translocation	NULL
,	NULL
or	NULL
the	NULL
phenotype	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

Because	NULL
BL	NULL
shows	NULL
heterogeneity	NULL
at	NULL
several	NULL
levels	NULL
,	NULL
in	NULL
particular	NULL
in	NULL
its	NULL
endemic	NULL
or	NULL
sporadic	NULL
forms	NULL
,	NULL
with	NULL
respect	NULL
to	NULL
the	NULL
type	NULL
of	NULL
translocation	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
,	NULL
t	NULL
(	NULL
2	NULL
;	NULL
8	NULL
)	NULL
,	NULL
t	NULL
(	NULL
8	NULL
;	NULL
:22	NULL
)	NULL
]	NULL
,	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
EBV	NULL
,	NULL
``	NULL
pattern	NULL
of	NULL
growth	NULL
(	NULL
as	NULL
clumps	NULL
or	NULL
single	NULL
cells	NULL
)	NULL
,	NULL
``	NULL
'	NULL
and	NULL
phenotype	NULL
,	NULL
``	NULL
we	NULL
chose	NULL
a	NULL
series	NULL
of	NULL
6	NULL
BL	NULL
lines	NULL
,	NULL
3	NULL
of	NULL
which	NULL
(	NULL
Daudi	NULL
,	NULL
Raji	NULL
,	NULL
Silti	NULL
)	NULL
show	NULL
high	NULL
and	NULL
the	NULL
other	NULL
3	NULL
(	NULL
Namalwa	NULL
,	NULL
S	NULL
$	NULL
T486	NULL
,	NULL
Pollik	NULL
)	NULL
show	NULL
low/negative	NULL
A-myb	NULL
expression	NULL
and	NULL
compared	NULL
A-myb	NULL
expression	NULL
with	NULL
the	NULL
known	NULL
and	NULL
observed	NULL
characteristics	NULL
of	NULL
the	NULL
lines	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
1	NULL
,	NULL
A-myb	NULL
expression	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
form	NULL
of	NULL
the	NULL
original	NULL
disease	NULL
(	NULL
endemic	NULL
or	NULL
sporadic	NULL
)	NULL
,	NULL
type	NULL
of	NULL
translocation	NULL
[	NULL
t	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
v	NULL
t	NULL
(	NULL
2	NULL
;	NULL
8	NULL
)	NULL
or	NULL
t	NULL
(	NULL
8	NULL
;	NULL
22	NULL
)	NULL
]	NULL
,	NULL
presence	NULL
of	NULL
EBV	NULL
,	NULL
or	NULL
pattern	NULL
of	NULL
growth	NULL
.	NULL

It	NULL
did	NULL
not	NULL
appear	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
particular	NULL
markers	NULL
known	NULL
to	NULL
vary	NULL
among	NULL
different	NULL
BL	NULL
Fig	NULL
4	NULL
.	NULL

A-myb	NULL
protein	NULL
expression	NULL
in	NULL
B-cell	NULL
lines	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
specificity	NULL
of	NULL
the	NULL
polyclonal	NULL
anti-A-myb	NULL
antiserum	NULL
was	NULL
tested	NULL
using	NULL
cellular	NULL
extracts	NULL
from	NULL
the	NULL
IM-9	NULL
myeloma	NULL
cell	NULL
line	NULL
stably	NULL
transfected	NULL
with	NULL
the	NULL
complete	NULL
A-myb	NULL
cDNA	NULL
or	NULL
with	NULL
the	NULL
empty	NULL
vector	NULL
.	NULL

An	NULL
extract	NULL
from	NULL
the	NULL
Daudi	NULL
cell	NULL
line	NULL
was	NULL
run	NULL
in	NULL
parallel	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
molecular-weight	NULL
markers	NULL
are	NULL
shown	NULL
and	NULL
that	NULL
of	NULL
the	NULL
90-kD	NULL
A-myb	NULL
doublet	NULL
is	NULL
indicated	NULL
with	NULL
a	NULL
black	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
and	NULL
C	NULL
)	NULL
Western	NULL
analysis	NULL
of	NULL
cellular	NULL
extracts	NULL
from	NULL
normal	NULL
CD38°	NULL
tonsillar	NULL
B	NULL
cells	NULL
(	NULL
lane	NULL
B	NULL
)	NULL
and	NULL
from	NULL
different	NULL
cell	NULL
lines	NULL
.	NULL

BL	NULL
lines	NULL
:	NULL
Daudi	NULL
(	NULL
1	NULL
)	NULL
,	NULL
Ramos	NULL
(	NULL
2	NULL
)	NULL
,	NULL
Raji	NULL
(	NULL
3	NULL
)	NULL
,	NULL
Silti	NULL
(	NULL
4	NULL
)	NULL
,	NULL
Pollik	NULL
(	NULL
5	NULL
)	NULL
,	NULL
Namalwa	NULL
(	NULL
6	NULL
)	NULL
,	NULL
$	NULL
ST486	NULL
(	NULL
7	NULL
)	NULL
.	NULL

EBV-LCL	NULL
:	NULL
CESS	NULL
(	NULL
1	NULL
)	NULL
,	NULL
Capo	NULL
(	NULL
2	NULL
)	NULL
Eli	NULL
(	NULL
3	NULL
)	NULL
.	NULL

Myelomas	NULL
:	NULL
IM-9	NULL
(	NULL
1	NULL
)	NULL
,	NULL
RPMI	NULL
8226	NULL
(	NULL
2	NULL
)	NULL
.	NULL

The	NULL
position	NULL
of	NULL
the	NULL
A-myb	NULL
specific	NULL
band	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

lines	NULL
(	NULL
CD10	NULL
,	NULL
23	NULL
,	NULL
30	NULL
,	NULL
39	NULL
,	NULL
70	NULL
,	NULL
77	NULL
)	NULL
or	NULL
classification	NULL
within	NULL
the	NULL
previously	NULL
defined	NULL
phenotypic	NULL
groups	NULL
.	NULL
``	NULL

Because	NULL
c-myc	NULL
rearrangement	NULL
and	NULL
consequent	NULL
deregulation	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
the	NULL
major	NULL
factor	NULL
in	NULL
the	NULL
pathogenesis	NULL
of	NULL
BL	NULL
,	NULL
*	NULL
we	NULL
wondered	NULL
whether	NULL
introduction	NULL
of	NULL
a	NULL
deregulated	NULL
c-mye	NULL
gene	NULL
in	NULL
EBV-LCL	NULL
could	NULL
lead	NULL
to	NULL
increased	NULL
expression	NULL
of	NULL
A-myb	NULL
more	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
BL	NULL
cell	NULL
lines	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
tested	NULL
in	NULL
Northern	NULL
analysis	NULL
a	NULL
series	NULL
of	NULL
EBV-LCL	NULL
clones	NULL
that	NULL
had	NULL
been	NULL
stably	NULL
transfected	NULL
with	NULL
a	NULL
construct	NULL
carrying	NULL
the	NULL
c-myc	NULL
gene	NULL
exons	NULL
2	NULL
and	NULL
3	NULL
downstream	NULL
of	NULL
the	NULL
SV40	NULL
promoter	NULL
.	NULL
``	NULL

The	NULL
cell	NULL
lines	NULL
used	NULL
had	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
express	NULL
intermediate	NULL
to	NULL
high	NULL
levels	NULL
of	NULL
the	NULL
exogenous	NULL
c-mye	NULL
protein	NULL
.	NULL

``	NULL
**	NULL
``	NULL
However	NULL
,	NULL
in	NULL
none	NULL
of	NULL
the	NULL
transfected	NULL
lines	NULL
could	NULL
we	NULL
detect	NULL
A-myb	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
deregulated	NULL
expression	NULL
of	NULL
c-myc	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
induce	NULL
A-myb	NULL
expression	NULL
in	NULL
this	NULL
cellular	NULL
context	NULL
.	NULL

Analysis	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
fresh	NULL
leukemic	NULL
samples	NULL
.	NULL

To	NULL
further	NULL
extend	NULL
our	NULL
analysis	NULL
of	NULL
A-myb	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
,	NULL
we	NULL
also	NULL
examined	NULL
a	NULL
large	NULL
panel	NULL
of	NULL
fresh	NULL
B-cell	NULL
leukemias	NULL
.	NULL

Non-T	NULL
lineage	NULL
ALL	NULL
can	NULL
be	NULL
classified	NULL
according	NULL
to	NULL
their	NULL
phenotype	NULL
in	NULL
3	NULL
subtypes	NULL
,	NULL
null	NULL
(	NULL
CD19*	NULL
,	NULL
CD10	NULL
,	NULL
slg~	NULL
)	NULL
,	NULL
common	NULL
(	NULL
CD19*	NULL
,	NULL
CDI10®	NULL
,	NULL
slg~	NULL
)	NULL
,	NULL
and	NULL
B	NULL
(	NULL
CD19®	NULL
,	NULL
CDI10®	NULL
,	NULL
sIg*	NULL
)	NULL
.	NULL
``	NULL

''	NULL
Cells	NULL
of	NULL
the	NULL
sIg*	NULL
B-cell	NULL
subtype	NULL
invariably	NULL
have	NULL
a	NULL
morphology	NULL
and	NULL
phenotype	NULL
indistinguishable	NULL
from	NULL
those	NULL
of	NULL
BL	NULL
cells	NULL
and	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
carry	NULL
c-mye	NULL
translocations	NULL
characteristic	NULL
of	NULL
BL	NULL
cells	NULL
.	NULL
``	NULL

Thus	NULL
,	NULL
we	NULL
screened	NULL
24	NULL
ALL	NULL
samples	NULL
,	NULL
of	NULL
which	NULL
6	NULL
were	NULL
null	NULL
,	NULL
11	NULL
were	NULL
common	NULL
,	NULL
and	NULL
7	NULL
were	NULL
of	NULL
the	NULL
sIg*	NULL
B-cell	NULL
subtype	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
5	NULL
,	NULL
all	NULL
common	NULL
and	NULL
null	NULL
ALL	NULL
were	NULL
very	NULL
weak	NULL
or	NULL
negative	NULL
for	NULL
A-myb	NULL
expression	NULL
,	NULL
whereas	NULL
all	NULL
7	NULL
B-ALL	NULL
samples	NULL
were	NULL
clearly	NULL
positive	NULL
for	NULL
A-myb	NULL
mRNA	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lanes	NULL
1	NULL
through	NULL
7	NULL
)	NULL
.	NULL

Of	NULL
note	NULL
is	NULL
that	NULL
the	NULL
normal	NULL
BM	NULL
control	NULL
sample	NULL
was	NULL
negative	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
1905	NULL
Table	NULL
1	NULL
.	NULL

Characteristics	NULL
of	NULL
A-myb	NULL
Positive	NULL
and	NULL
Negative	NULL
BL	NULL
Lines	NULL
Surface	NULL
Phenotype	NULL
Line	NULL
Type	NULL
Translocation	NULL
EBV	NULL
Growth	NULL
CD10	NULL
CD23	NULL
CD30	NULL
CD39	NULL
CD70	NULL
CD77	NULL
Group*	NULL
A-myb	NULL
Daudi	NULL
E	NULL
8:14	NULL
+	NULL
SC	NULL
+++	NULL
-	NULL
I	NULL
High	NULL
Raji	NULL
E	NULL
8:14	NULL
+	NULL
SMC	NULL
+++	NULL
++	NULL
+	NULL
++	NULL
+	NULL
II	NULL
High	NULL
Silti	NULL
S	NULL
2	NULL
;	NULL
8	NULL
-	NULL
LC	NULL
+++	NULL
-	NULL
+	NULL
+	NULL
++	NULL
I/II	NULL
High	NULL
Namalwa	NULL
E	NULL
8	NULL
;	NULL
14	NULL
+	NULL
SC	NULL
+++	NULL
-	NULL
-	NULL
+4	NULL
I/II	NULL
Barely	NULL
detectable	NULL
$	NULL
T486	NULL
5	NULL
8	NULL
;	NULL
14	NULL
SC	NULL
+++	NULL
+	NULL
+	NULL
I/II	NULL
Barely	NULL
detectable	NULL
Pollik	NULL
S	NULL
8:14	NULL
+	NULL
LC	NULL
-	NULL
++	NULL
+++	NULL
++	NULL
-	NULL
III	NULL
Negative	NULL
Abbreviations	NULL
:	NULL
E	NULL
,	NULL
endemic	NULL
;	NULL
S	NULL
,	NULL
sporadic	NULL
;	NULL
SC	NULL
,	NULL
mostly	NULL
single	NULL
cells	NULL
;	NULL
SMC	NULL
,	NULL
small	NULL
to	NULL
medium	NULL
clumps	NULL
;	NULL
LC	NULL
,	NULL
large	NULL
clumps	NULL
;	NULL
6	NULL
%	NULL
-20	NULL
%	NULL
;	NULL
++	NULL
,	NULL
21	NULL
%	NULL
-80	NULL
%	NULL
;	NULL
+++	NULL
,	NULL
>	NULL
80	NULL
%	NULL
positive	NULL
cells	NULL
.	NULL

*	NULL
Phenotypic	NULL
group	NULL
.	NULL
``	NULL

''	NULL
the	NULL
BM	NULL
sample	NULL
collected	NULL
during	NULL
the	NULL
leukemic	NULL
phase	NULL
of	NULL
a	NULL
BL	NULL
patient	NULL
was	NULL
also	NULL
strongly	NULL
positive	NULL
for	NULL
A-myb	NULL
(	NULL
Fig	NULL
6	NULL
,	NULL
lane	NULL
8	NULL
)	NULL
.	NULL

In	NULL
all	NULL
blots	NULL
,	NULL
a	NULL
positive	NULL
control	NULL
consisting	NULL
of	NULL
RNA	NULL
from	NULL
a	NULL
BL	NULL
cell	NULL
line	NULL
was	NULL
included	NULL
to	NULL
control	NULL
for	NULL
the	NULL
level	NULL
of	NULL
hybridization	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
also	NULL
among	NULL
fresh	NULL
leukemic	NULL
samples	NULL
,	NULL
A-myb	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
cells	NULL
of	NULL
the	NULL
more	NULL
mature	NULL
B	NULL
(	NULL
slg*	NULL
)	NULL
type	NULL
.	NULL

It	NULL
is	NULL
of	NULL
particular	NULL
interest	NULL
that	NULL
all	NULL
cases	NULL
of	NULL
BALL	NULL
tested	NULL
so	NULL
far	NULL
were	NULL
found	NULL
to	NULL
be	NULL
positive	NULL
for	NULL
A-myb	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
this	NULL
may	NULL
be	NULL
a	NULL
constant	NULL
characteristic	NULL
of	NULL
this	NULL
subtype	NULL
of	NULL
B-cell	NULL
leukemias	NULL
.	NULL

The	NULL
same	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
c-myb	NULL
and	NULL
B-myb	NULL
probes	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
were	NULL
well	NULL
expressed	NULL
in	NULL
most	NULL
samples	NULL
,	NULL
regardless	NULL
of	NULL
ALL	NULL
subgroup	NULL
.	NULL

As	NULL
for	NULL
the	NULL
cell	NULL
lines	NULL
,	NULL
some	NULL
variability	NULL
of	NULL
expression	NULL
was	NULL
observed	NULL
within	NULL
each	NULL
subgroup	NULL
(	NULL
Figs	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
also	NULL
in	NULL
fresh	NULL
cases	NULL
of	NULL
ALL	NULL
,	NULL
A-myb	NULL
expression	NULL
is	NULL
restricted	NULL
to	NULL
a	NULL
particular	NULL
subset	NULL
whereas	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
is	NULL
not	NULL
.	NULL

To	NULL
extend	NULL
the	NULL
analysis	NULL
of	NULL
A-myb	NULL
expression	NULL
to	NULL
other	NULL
mature	NULL
B-cell	NULL
leukemias	NULL
that	NULL
could	NULL
represent	NULL
different	NULL
B-cell	NULL
differentiation	NULL
stages	NULL
and/or	NULL
subsets	NULL
,	NULL
we	NULL
tested	NULL
20	NULL
B-CLL	NULL
and	NULL
4	NULL
PLL	NULL
samples	NULL
for	NULL
A-myb	NULL
RNA	NULL
expression	NULL
.	NULL

As	NULL
shown	NULL
,	NULL
<	NULL
5	NULL
%	NULL
positive	NULL
cells	NULL
;	NULL
+	NULL
,	NULL
in	NULL
Fig	NULL
7	NULL
,	NULL
A-myb	NULL
expression	NULL
was	NULL
heterogeneous	NULL
in	NULL
the	NULL
B-CLL	NULL
samples	NULL
:	NULL
out	NULL
of	NULL
20	NULL
cases	NULL
,	NULL
5	NULL
showed	NULL
strong	NULL
expression	NULL
(	NULL
25	NULL
%	NULL
,	NULL
cases	NULL
1	NULL
,	NULL
9	NULL
,	NULL
16	NULL
,	NULL
17	NULL
,	NULL
and	NULL
19	NULL
)	NULL
,	NULL
5	NULL
were	NULL
weakly	NULL
positive	NULL
(	NULL
25	NULL
%	NULL
,	NULL
cases	NULL
4	NULL
,	NULL
7	NULL
,	NULL
10	NULL
,	NULL
13	NULL
,	NULL
and	NULL
15	NULL
)	NULL
and	NULL
all	NULL
the	NULL
others	NULL
(	NULL
50	NULL
%	NULL
)	NULL
were	NULL
negative	NULL
for	NULL
A-myb	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
A-myb	NULL
in	NULL
CLL	NULL
correlated	NULL
neither	NULL
with	NULL
Rai	NULL
stage	NULL
nor	NULL
with	NULL
other	NULL
parameters	NULL
such	NULL
as	NULL
blood	NULL
cell	NULL
counts	NULL
(	NULL
Table	NULL
2	NULL
)	NULL
or	NULL
the	NULL
CD38	NULL
,	NULL
CD39	NULL
phenotype	NULL
of	NULL
the	NULL
CLL	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
A-myb	NULL
expression	NULL
seemed	NULL
relatively	NULL
stable	NULL
over	NULL
time	NULL
in	NULL
that	NULL
two	NULL
patients	NULL
who	NULL
had	NULL
shown	NULL
intermediate	NULL
or	NULL
negative	NULL
A-myb	NULL
expression	NULL
were	NULL
found	NULL
to	NULL
maintain	NULL
these	NULL
characteristics	NULL
several	NULL
years	NULL
following	NULL
the	NULL
first	NULL
sampling	NULL
and	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A-myb	NULL
expression	NULL
in	NULL
13	NULL
ALL	NULL
and	NULL
12	NULL
CLL	NULL
samples	NULL
could	NULL
be	NULL
quantified	NULL
by	NULL
densitometric	NULL
analysis	NULL
because	NULL
they	NULL
were	NULL
present	NULL
on	NULL
blots	NULL
that	NULL
carried	NULL
an	NULL
identical	NULL
positive	NULL
RNA	NULL
sample	NULL
to	NULL
use	NULL
as	NULL
reference	NULL
RNA	NULL
to	NULL
compare	NULL
the	NULL
different	NULL
blots	NULL
.	NULL

The	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
Fig	NULL
8	NULL
and	NULL
clearly	NULL
demonstrate	NULL
that	NULL
A-myb	NULL
is	NULL
expressed	NULL
at	NULL
much	NULL
higher	NULL
levels	NULL
in	NULL
the	NULL
B-ALL	NULL
relative	NULL
to	NULL
the	NULL
null	NULL
and	NULL
common	NULL
ALL	NULL
samples	NULL
and	NULL
at	NULL
comparably	NULL
high	NULL
levels	NULL
also	NULL
in	NULL
a	NULL
small	NULL
subset	NULL
of	NULL
CLL	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
were	NULL
also	NULL
tested	NULL
on	NULL
the	NULL
same	NULL
blots	NULL
.	NULL

null	NULL
and	NULL
common	NULL
ALL	NULL
1	NULL
2	NULL
3	NULL
Fig	NULL
5	NULL
.	NULL

Myb	NULL
mRNA	NULL
expression	NULL
in	NULL
null	NULL
and	NULL
common	NULL
ALL	NULL
.	NULL

Northern	NULL
blot	NULL
analysis	NULL
of	NULL
total	NULL
RNA	NULL
extracted	NULL
from	NULL
fresh	NULL
BM	NULL
samples	NULL
of	NULL
ALL	NULL
patients	NULL
.	NULL

A	NULL
representative	NULL
positive	NULL
control	NULL
is	NULL
shown	NULL
on	NULL
the	NULL
right	NULL
(	NULL
Daudi	NULL
cell	NULL
line	NULL
RNA	NULL
)	NULL
.	NULL

Lanes	NULL
1	NULL
through	NULL
5	NULL
and	NULL
9	NULL
contained	NULL
RNA	NULL
from	NULL
null	NULL
ALL	NULL
samples	NULL
and	NULL
lanes	NULL
6	NULL
through	NULL
8	NULL
and	NULL
10	NULL
through	NULL
17	NULL
from	NULL
common	NULL
ALL	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

The	NULL
photographs	NULL
of	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
blots	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

CS	NULL
J	NULL
13	NULL
14	NULL
1516	NULL
17	NULL
0°	NULL
%	NULL
9	NULL
10	NULL
11	NULL
12	NULL
j	NULL
|	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
c-myb	NULL
was	NULL
weakly	NULL
expressed	NULL
in	NULL
two	NULL
patients	NULL
(	NULL
cases	NULL
7	NULL
and	NULL
15	NULL
)	NULL
and	NULL
was	NULL
strong	NULL
only	NULL
in	NULL
one	NULL
case	NULL
(	NULL
number	NULL
13	NULL
)	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

C-myb	NULL
expression	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
A-myb	NULL
.	NULL

B-myb	NULL
,	NULL
on	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
was	NULL
undetectable	NULL
in	NULL
all	NULL
20	NULL
cases	NULL
.	NULL

Thus	NULL
,	NULL
again	NULL
in	NULL
the	NULL
case	NULL
of	NULL
CLL	NULL
,	NULL
A-myb	NULL
expression	NULL
was	NULL
distinct	NULL
from	NULL
that	NULL
of	NULL
the	NULL
other	NULL
two	NULL
myb	NULL
genes	NULL
.	NULL

Nine	NULL
of	NULL
the	NULL
20	NULL
CLL	NULL
samples	NULL
were	NULL
also	NULL
hybridized	NULL
with	NULL
the	NULL
c-myc	NULL
probe	NULL
;	NULL
C-mye	NULL
expression	NULL
in	NULL
CLL	NULL
was	NULL
variable	NULL
but	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
A-myb	NULL
or	NULL
c-myb	NULL
expression	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
4	NULL
PLL	NULL
samples	NULL
were	NULL
collected	NULL
and	NULL
tested	NULL
for	NULL
A-myb	NULL
expression	NULL
.	NULL

All	NULL
cases	NULL
were	NULL
negative	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

GOLAY	NULL
ET	NULL
AL	NULL
Fig	NULL
6	NULL
.	NULL

Myb	NULL
mRNA	NULL
expression	NULL
in	NULL
fresh	NULL
B-ALL	NULL
and	NULL
BL	NULL
.	NULL

RNA	NULL
from	NULL
7	NULL
sig*	NULL
B-ALL	NULL
(	NULL
lanes	NULL
1	NULL
through	NULL
7	NULL
)	NULL
and	NULL
from	NULL
1	NULL
BL	NULL
patient	NULL
with	NULL
BM	NULL
involvement	NULL
(	NULL
lane	NULL
8	NULL
)	NULL
were	NULL
analyzed	NULL
in	NULL
Northern	NULL
blots	NULL
.	NULL

RNA	NULL
from	NULL
a	NULL
normal	NULL
BM	NULL
sample	NULL
(	NULL
BM	NULL
)	NULL
was	NULL
also	NULL
used	NULL
as	NULL
a	NULL
control	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

The	NULL
photographs	NULL
of	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
blots	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

Loss	NULL
of	NULL
A-myb	NULL
expression	NULL
during	NULL
progression	NULL
of	NULL
a	NULL
CLL	NULL
case	NULL
in	NULL
Richter	NULL
's	NULL
syndrome	NULL
(	NULL
RS	NULL
)	NULL
.	NULL

-	NULL
Our	NULL
present	NULL
and	NULL
previous	NULL
data	NULL
show	NULL
that	NULL
A-myb	NULL
expression	NULL
correlates	NULL
with	NULL
a	NULL
restricted	NULL
stage	NULL
of	NULL
B-cell	NULL
differentiation	NULL
and	NULL
not	NULL
simply	NULL
with	NULL
prolifera-tion	NULL
.	NULL

In	NULL
3	NULL
%	NULL
to	NULL
5	NULL
%	NULL
of	NULL
patients	NULL
with	NULL
the	NULL
CLL	NULL
,	NULL
this	NULL
neoplasm	NULL
progresses	NULL
into	NULL
a	NULL
more	NULL
malignant	NULL
large	NULL
cell	NULL
lymphoma	NULL
called	NULL
RS	NULL
.	NULL
``	NULL

The	NULL
large	NULL
Richter	NULL
's	NULL
cells	NULL
have	NULL
altered	NULL
morphology	NULL
and	NULL
in	NULL
part	NULL
phenotype	NULL
relative	NULL
to	NULL
the	NULL
CLL	NULL
cells	NULL
,	NULL
but	NULL
they	NULL
are	NULL
generally	NULL
derived	NULL
from	NULL
the	NULL
same	NULL
clone	NULL
.	NULL

``	NULL
``	NULL
``	NULL
``	NULL
*	NULL
Therefore	NULL
,	NULL
we	NULL
wondered	NULL
whether	NULL
the	NULL
clonal	NULL
evolution	NULL
observed	NULL
in	NULL
RS	NULL
could	NULL
also	NULL
be	NULL
associated	NULL
with	NULL
a	NULL
change	NULL
in	NULL
A-myb	NULL
expression	NULL
.	NULL

One	NULL
CLL	NULL
G	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
14	NULL
15	NULL
16	NULL
17	NULL
18	NULL
19	NULL
20	NULL
&	NULL
``	NULL
Fig	NULL
7	NULL
.	NULL

Myb	NULL
mRNA	NULL
expression	NULL
B-CLL	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
blood	NULL
samples	NULL
from	NULL
CLL	NULL
patients	NULL
and	NULL
analyzed	NULL
for	NULL
A-myb	NULL
expression	NULL
in	NULL
Northern	NULL
blots	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
hybridized	NULL
with	NULL
the	NULL
indicated	NULL
probes	NULL
.	NULL

The	NULL
photographs	NULL
of	NULL
the	NULL
ethidium	NULL
bromide-stained	NULL
blots	NULL
are	NULL
also	NULL
shown	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
Table	NULL
2	NULL
.	NULL

Characteristics	NULL
of	NULL
B-CLL	NULL
Patients	NULL
1907	NULL
PLL	NULL
Patient	NULL
No	NULL
.	NULL

*	NULL
RAl	NULL
Stage	NULL
k/A	NULL
CD5	NULL
Leukocytes/pL	NULL
__	NULL
A-myb	NULL
mRNAt	NULL
17	NULL
I	NULL
K	NULL
+	NULL
32,000	NULL
++	NULL
1	NULL
II	NULL
K	NULL
+	NULL
240,000	NULL
+++	NULL
12	NULL
II	NULL
A	NULL
+	NULL
61,000	NULL
~-	NULL
1	NULL
16	NULL
II	NULL
K	NULL
-	NULL
57,000	NULL
++	NULL
2	NULL
III	NULL
K	NULL
+	NULL
68,000	NULL
3	NULL
III	NULL
A	NULL
-	NULL
24,000	NULL
8	NULL
III	NULL
k	NULL
+	NULL
280,000	NULL
9	NULL
III	NULL
ND	NULL
+	NULL
164,000	NULL
++	NULL
14	NULL
III	NULL
ND	NULL
+	NULL
23,000	NULL
19	NULL
III	NULL
K	NULL
+	NULL
82,000	NULL
++	NULL
20	NULL
III	NULL
A	NULL
+	NULL
148,000	NULL
=	NULL
10	NULL
IV	NULL
K	NULL
+	NULL
129,000	NULL
+	NULL
18	NULL
IV	NULL
K	NULL
+	NULL
100,000	NULL
*	NULL
The	NULL
patient	NULL
number	NULL
corresponds	NULL
to	NULL
those	NULL
of	NULL
Fig	NULL
4.	NULL
t	NULL
The	NULL
+/-	NULL
signs	NULL
refer	NULL
to	NULL
the	NULL
intensity	NULL
of	NULL
the	NULL
A-myb	NULL
signal	NULL
as	NULL
shown	NULL
in	NULL
Fig	NULL
4.	NULL
case	NULL
of	NULL
RS	NULL
presented	NULL
with	NULL
both	NULL
large	NULL
and	NULL
small	NULL
lymphocytes	NULL
in	NULL
the	NULL
PB	NULL
clearly	NULL
separable	NULL
by	NULL
FACS	NULL
analysis	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
size	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Table	NULL
3	NULL
,	NULL
phenotypic	NULL
analysis	NULL
of	NULL
these	NULL
two	NULL
populations	NULL
showed	NULL
that	NULL
the	NULL
small	NULL
cell	NULL
population	NULL
contains	NULL
about	NULL
40	NULL
%	NULL
T	NULL
lymphocytes	NULL
(	NULL
CD3*	NULL
)	NULL
and	NULL
56	NULL
%	NULL
CD20®	NULL
,	NULL
Clinical	NULL
samples	NULL
200	NULL
-	NULL
|	NULL
|	NULL
|	NULL
I	NULL
|	NULL
|	NULL
|	NULL
|	NULL
|	NULL
w	NULL
i	NULL
|	NULL
@	NULL
|	NULL
|	NULL
5	NULL
|	NULL
ce	NULL
D	NULL
:	NULL
|	NULL
e	NULL
|	NULL
|	NULL
2	NULL
100	NULL
-	NULL
|	NULL
|	NULL
|	NULL
.	NULL

>	NULL
a	NULL
'	NULL
bol	NULL
U	NULL
J	NULL
$	NULL
o	NULL
*	NULL
=p	NULL
$	NULL
5	NULL
.	NULL

4	NULL
wl	NULL
|	NULL
|	NULL
|	NULL
I	NULL
@	NULL
o	NULL
I	NULL
l	NULL
s-	NULL
!	NULL

|	NULL
&	NULL
!	NULL

M	NULL
pre-B	NULL
+	NULL
B-ALL	NULL
CLL	NULL
comm	NULL
.	NULL

ALL	NULL
Fig	NULL
8	NULL
.	NULL

-	NULL
Densitometric	NULL
analysis	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
ALL	NULL
and	NULL
CLL	NULL
.	NULL

The	NULL
A-myb	NULL
signals	NULL
from	NULL
several	NULL
blots	NULL
containing	NULL
a	NULL
reference	NULL
RNA	NULL
were	NULL
measured	NULL
by	NULL
densitometric	NULL
analysis	NULL
and	NULL
normalized	NULL
for	NULL
both	NULL
total	NULL
RNA	NULL
content	NULL
and	NULL
reference	NULL
RNA	NULL
.	NULL

The	NULL
results	NULL
are	NULL
presented	NULL
as	NULL
arbitrary	NULL
O.D	NULL
.	NULL

units	NULL
.	NULL

Fig	NULL
9	NULL
.	NULL

A-myb	NULL
mRNA	NULL
expression	NULL
in	NULL
B-PLL	NULL
.	NULL

Four	NULL
B-PLL	NULL
samples	NULL
were	NULL
analyzed	NULL
for	NULL
A-myb	NULL
expression	NULL
by	NULL
Northern	NULL
analysis	NULL
.	NULL

The	NULL
hybridization	NULL
results	NULL
with	NULL
A-myb	NULL
and	NULL
the	NULL
-actin	NULL
probe	NULL
as	NULL
control	NULL
are	NULL
shown	NULL
.	NULL

CDS*	NULL
,	NULL
A*	NULL
CLL	NULL
B	NULL
cells	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
the	NULL
large	NULL
,	NULL
blast	NULL
cells	NULL
were	NULL
essentially	NULL
all	NULL
CD20*	NULL
,	NULL
A*	NULL
,	NULL
and	NULL
CDS~	NULL
Richter	NULL
's	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
light-chain	NULL
isotype	NULL
suggested	NULL
that	NULL
the	NULL
Richter	NULL
's	NULL
cells	NULL
were	NULL
a	NULL
clonal	NULL
evolution	NULL
of	NULL
the	NULL
CLL	NULL
,	NULL
as	NULL
reported	NULL
for	NULL
the	NULL
majority	NULL
of	NULL
Richter	NULL
's	NULL
cases	NULL
.	NULL
``	NULL

''	NULL
To	NULL
determine	NULL
whether	NULL
evolution	NULL
of	NULL
the	NULL
CLL	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
change	NULL
in	NULL
A-myb	NULL
expression	NULL
,	NULL
we	NULL
separated	NULL
the	NULL
small	NULL
and	NULL
large	NULL
CD20*	NULL
B	NULL
cells	NULL
by	NULL
cell	NULL
sorting	NULL
on	NULL
the	NULL
FACS	NULL
and	NULL
purified	NULL
total	NULL
RNA	NULL
from	NULL
these	NULL
cells	NULL
.	NULL

The	NULL
levels	NULL
of	NULL
A-myb	NULL
expression	NULL
were	NULL
measured	NULL
by	NULL
a	NULL
quantitative	NULL
PCR	NULL
method	NULL
used	NULL
successfully	NULL
pre-viously	NULL
.	NULL
``	NULL

''	NULL
As	NULL
a	NULL
standard	NULL
the	NULL
actin	NULL
gene	NULL
was	NULL
amplified	NULL
from	NULL
the	NULL
same	NULL
reverse	NULL
transcribed	NULL
samples	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
10	NULL
,	NULL
although	NULL
equivalent	NULL
levels	NULL
of	NULL
actin	NULL
could	NULL
be	NULL
seen	NULL
in	NULL
both	NULL
small	NULL
and	NULL
large	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
levels	NULL
of	NULL
A-myb	NULL
were	NULL
approximately	NULL
25-fold	NULL
lower	NULL
in	NULL
the	NULL
large	NULL
B	NULL
(	NULL
Richter	NULL
)	NULL
B	NULL
cells	NULL
relative	NULL
to	NULL
the	NULL
small	NULL
(	NULL
CLL	NULL
)	NULL
B-cell	NULL
population	NULL
.	NULL

These	NULL
data	NULL
show	NULL
that	NULL
the	NULL
evolution	NULL
into	NULL
RS	NULL
in	NULL
this	NULL
patient	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
drastic	NULL
reduction	NULL
in	NULL
A-myb	NULL
gene	NULL
expression	NULL
.	NULL

Table	NULL
3	NULL
.	NULL

Phenotype	NULL
of	NULL
Small	NULL
(	NULL
CLL	NULL
)	NULL
and	NULL
Large	NULL
(	NULL
Richter	NULL
)	NULL
Mononuclear	NULL
Cells	NULL
of	NULL
RS	NULL
Patient	NULL
%	NULL
Positive	NULL
Cells	NULL
Surface	NULL
Antigen	NULL
Small	NULL
Large	NULL
CD20	NULL
56.4	NULL
93.3	NULL
CD19	NULL
52.4	NULL
91.8	NULL
CD3	NULL
42.0	NULL
1.4	NULL
CD14	NULL
1.0	NULL
4.0	NULL
K	NULL
15.2	NULL
11.6	NULL
A	NULL
58.7	NULL
95.7	NULL
CD10	NULL
<	NULL
1	NULL
<	NULL
1	NULL
CD5	NULL
77	NULL
%	NULL
4.7	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1908	NULL
B-actin	NULL
#	NULL
p	NULL
an	NULL
as	NULL
an	NULL
«	NULL
UJ	NULL
Relative	NULL
A-myb	NULL
levels	NULL
Total	NULL
Large	NULL
Small	NULL
Fig	NULL
10	NULL
.	NULL

Expression	NULL
of	NULL
A-myb	NULL
in	NULL
the	NULL
CLL	NULL
and	NULL
Richter	NULL
's	NULL
cells	NULL
from	NULL
the	NULL
same	NULL
patient	NULL
.	NULL

PB	NULL
mononuclear	NULL
cells	NULL
from	NULL
one	NULL
RS	NULL
patient	NULL
were	NULL
stained	NULL
with	NULL
an	NULL
anti-CD20	NULL
antibody	NULL
.	NULL

The	NULL
small	NULL
and	NULL
large	NULL
CD20*	NULL
populations	NULL
were	NULL
isolated	NULL
by	NULL
sorting	NULL
on	NULL
the	NULL
FACS	NULL
and	NULL
expression	NULL
of	NULL
A-myb	NULL
or	NULL
B-actin	NULL
was	NULL
analyzed	NULL
by	NULL
semi-quantitative	NULL
PCR	NULL
amplification	NULL
of	NULL
6	NULL
ng	NULL
of	NULL
purified	NULL
total	NULL
RNA	NULL
from	NULL
each	NULL
sample	NULL
in	NULL
duplicate	NULL
.	NULL

RNA	NULL
from	NULL
the	NULL
unsorted	NULL
cells	NULL
was	NULL
also	NULL
amplified	NULL
in	NULL
parallel	NULL
(	NULL
Total	NULL
)	NULL
.	NULL

The	NULL
amplification	NULL
products	NULL
were	NULL
run	NULL
on	NULL
an	NULL
agarose	NULL
gel	NULL
,	NULL
blotted	NULL
,	NULL
and	NULL
analyzed	NULL
by	NULL
hybridization	NULL
with	NULL
A-myb	NULL
or	NULL
B-actin	NULL
specific	NULL
probes	NULL
.	NULL

The	NULL
results	NULL
of	NULL
the	NULL
hybridization	NULL
are	NULL
shown	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
-actin	NULL
and	NULL
A-myb	NULL
specific	NULL
signals	NULL
for	NULL
each	NULL
population	NULL
were	NULL
quantified	NULL
by	NULL
densitometry	NULL
and	NULL
the	NULL
results	NULL
are	NULL
shown	NULL
in	NULL
(	NULL
B	NULL
)	NULL
.	NULL

DISCUSSION	NULL
In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
described	NULL
the	NULL
pattern	NULL
of	NULL
A-myb	NULL
gene	NULL
expression	NULL
in	NULL
an	NULL
extended	NULL
panel	NULL
of	NULL
human	NULL
B	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
cell	NULL
lines	NULL
and	NULL
fresh	NULL
samples	NULL
,	NULL
representing	NULL
different	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
and/or	NULL
B-cell	NULL
sub-sets	NULL
.	NULL

A-myb	NULL
expression	NULL
was	NULL
also	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
related	NULL
c-myb	NULL
and	NULL
B-myb	NULL
genes	NULL
in	NULL
the	NULL
same	NULL
samples	NULL
.	NULL

The	NULL
results	NULL
show	NULL
that	NULL
A-myb	NULL
expression	NULL
,	NULL
unlike	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
is	NULL
restricted	NULL
to	NULL
cells	NULL
with	NULL
a	NULL
Burkitt-like	NULL
morphol-ogy	NULL
,	NULL
that	NULL
is	NULL
to	NULL
BL	NULL
and	NULL
ALL	NULL
of	NULL
the	NULL
B	NULL
(	NULL
slg*	NULL
)	NULL
type	NULL
,	NULL
but	NULL
is	NULL
GOLAY	NULL
ET	NULL
AL	NULL
absent	NULL
from	NULL
most	NULL
other	NULL
leukemias	NULL
.	NULL

Seventy-one	NULL
percent	NULL
of	NULL
BL	NULL
lines	NULL
expressed	NULL
intermediate	NULL
to	NULL
very	NULL
high	NULL
levels	NULL
of	NULL
A-myb	NULL
,	NULL
either	NULL
as	NULL
RNA	NULL
or	NULL
as	NULL
protein	NULL
,	NULL
and	NULL
7	NULL
of	NULL
7	NULL
B-ALL	NULL
(	NULL
slg*	NULL
)	NULL
as	NULL
well	NULL
as	NULL
one	NULL
fresh	NULL
BL	NULL
sample	NULL
tested	NULL
were	NULL
also	NULL
clearly	NULL
positive	NULL
for	NULL
A-myb	NULL
.	NULL

Other	NULL
fresh	NULL
leukemia	NULL
samples	NULL
tested	NULL
,	NULL
including	NULL
17	NULL
null	NULL
and	NULL
common	NULL
ALL	NULL
,	NULL
4	NULL
PLL	NULL
,	NULL
or	NULL
B-cell	NULL
lines	NULL
including	NULL
6	NULL
myeloma	NULL
,	NULL
4	NULL
NHL	NULL
,	NULL
and	NULL
2	NULL
pre-B	NULL
ALL	NULL
did	NULL
not	NULL
express	NULL
A-myb	NULL
significantly	NULL
.	NULL

Perhaps	NULL
surprisingly	NULL
,	NULL
25	NULL
%	NULL
of	NULL
the	NULL
cases	NULL
of	NULL
CLL	NULL
also	NULL
showed	NULL
strong	NULL
A-myb	NULL
expression	NULL
.	NULL

Finally	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
evolution	NULL
of	NULL
a	NULL
CLL	NULL
case	NULL
into	NULL
RS	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
25-fold	NULL
decrease	NULL
in	NULL
A-myb	NULL
expression	NULL
.	NULL

A-myb	NULL
expression	NULL
in	NULL
BL	NULL
cells	NULL
was	NULL
very	NULL
strong	NULL
in	NULL
most	NULL
cell	NULL
lines	NULL
but	NULL
weak	NULL
or	NULL
negative	NULL
in	NULL
some	NULL
of	NULL
them	NULL
(	NULL
29	NULL
%	NULL
)	NULL
.	NULL

This	NULL
heterogeneity	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
any	NULL
of	NULL
the	NULL
parameters	NULL
considered	NULL
(	NULL
type	NULL
of	NULL
translocation	NULL
,	NULL
presence	NULL
of	NULL
EBV	NULL
,	NULL
phenotype	NULL
,	NULL
growth	NULL
pattern	NULL
)	NULL
.	NULL

A	NULL
lack	NULL
of	NULL
A-myb	NULL
expression	NULL
could	NULL
have	NULL
been	NULL
due	NULL
to	NULL
loss	NULL
of	NULL
expression	NULL
during	NULL
culture	NULL
in	NULL
vitro	NULL
because	NULL
it	NULL
is	NULL
well	NULL
known	NULL
that	NULL
many	NULL
phenotypic	NULL
and	NULL
genetic	NULL
alterations	NULL
take	NULL
place	NULL
during	NULL
long-term	NULL
in	NULL
vitro	NULL
culture	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
finding	NULL
that	NULL
all	NULL
7	NULL
sIg*t	NULL
B-ALL	NULL
cases	NULL
as	NULL
well	NULL
as	NULL
1	NULL
fresh	NULL
BL	NULL
sample	NULL
with	NULL
BM	NULL
involvement	NULL
were	NULL
positive	NULL
for	NULL
A-myb	NULL
expression	NULL
suggests	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
this	NULL
gene	NULL
may	NULL
be	NULL
a	NULL
constant	NULL
characteristic	NULL
of	NULL
these	NULL
types	NULL
of	NULL
leukemias/lympho-mas	NULL
.	NULL
``	NULL

A	NULL
more	NULL
accurate	NULL
evaluation	NULL
of	NULL
whether	NULL
A-myb	NULL
expression	NULL
is	NULL
always	NULL
associated	NULL
with	NULL
BLs/B-ALL	NULL
will	NULL
require	NULL
analysis	NULL
of	NULL
a	NULL
larger	NULL
number	NULL
of	NULL
cases	NULL
of	NULL
these	NULL
relatively	NULL
rare	NULL
neoplasias	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
A-myb	NULL
expression	NULL
is	NULL
restricted	NULL
nearly	NULL
exclusively	NULL
to	NULL
BL	NULL
and	NULL
mature	NULL
B-ALL	NULL
cells	NULL
is	NULL
particularly	NULL
interesting	NULL
because	NULL
the	NULL
neoplastic	NULL
B	NULL
cells	NULL
from	NULL
these	NULL
two	NULL
diseases	NULL
are	NULL
phenotypically	NULL
and	NULL
morphologically	NULL
identical	NULL
and	NULL
both	NULL
present	NULL
the	NULL
typical	NULL
translocations	NULL
involving	NULL
the	NULL
c-mye	NULL
and	NULL
Ig	NULL
genes	NULL
.	NULL
``	NULL

Our	NULL
previous	NULL
data	NULL
had	NULL
shown	NULL
that	NULL
in	NULL
normal	NULL
tonsillar	NULL
B	NULL
lymphocytes	NULL
,	NULL
A-myb	NULL
is	NULL
strongly	NULL
expressed	NULL
in	NULL
activated	NULL
germinal	NULL
center	NULL
B	NULL
lymphocytes	NULL
with	NULL
the	NULL
phenotype	NULL
CD38*	NULL
,	NULL
CD39~	NULL
,	NULL
sIgM	NULL
.	NULL

*	NULL
``	NULL
Also	NULL
,	NULL
the	NULL
phenotype	NULL
of	NULL
BL	NULL
and	NULL
B-ALL	NULL
cells	NULL
,	NULL
in	NULL
particular	NULL
with	NULL
respect	NULL
to	NULL
expression	NULL
of	NULL
CD38	NULL
,	NULL
CD39	NULL
,	NULL
CD77	NULL
,	NULL
CD10	NULL
,	NULL
suggests	NULL
that	NULL
they	NULL
derive	NULL
from	NULL
germinal	NULL
center	NULL
(	NULL
GC	NULL
)	NULL
cells	NULL
.	NULL

***	NULL
``	NULL
``	NULL
``	NULL
``	NULL
°	NULL
In	NULL
addition	NULL
,	NULL
both	NULL
BL	NULL
and	NULL
germinal	NULL
center	NULL
B	NULL
cells	NULL
are	NULL
prone	NULL
to	NULL
apoptosis	NULL
,	NULL
again	NULL
suggesting	NULL
that	NULL
BL	NULL
derive	NULL
from	NULL
GC	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
``	NULL
``	NULL
Our	NULL
data	NULL
on	NULL
A-myb	NULL
expression	NULL
add	NULL
further	NULL
evidence	NULL
to	NULL
this	NULL
hypothesis	NULL
and	NULL
suggest	NULL
that	NULL
A-myb	NULL
expression	NULL
in	NULL
BL	NULL
and	NULL
B-ALL	NULL
may	NULL
at	NULL
least	NULL
in	NULL
part	NULL
reflect	NULL
the	NULL
phenotype	NULL
of	NULL
their	NULL
normal	NULL
B-cell	NULL
counterpart	NULL
.	NULL

The	NULL
study	NULL
of	NULL
the	NULL
expression	NULL
of	NULL
A-myb	NULL
may	NULL
thus	NULL
help	NULL
understand	NULL
the	NULL
biological	NULL
characteristics	NULL
of	NULL
the	NULL
normal	NULL
and	NULL
neoplastic	NULL
B	NULL
cells	NULL
that	NULL
express	NULL
this	NULL
transcription	NULL
factor	NULL
as	NULL
well	NULL
as	NULL
the	NULL
pathogenesis	NULL
of	NULL
BL	NULL
and	NULL
B-ALL	NULL
.	NULL

A-myb	NULL
RNA	NULL
expression	NULL
was	NULL
high	NULL
in	NULL
BL	NULL
and	NULL
B-ALL	NULL
.	NULL

Also	NULL
at	NULL
the	NULL
protein	NULL
level	NULL
,	NULL
A-myb	NULL
expression	NULL
was	NULL
5-	NULL
to	NULL
10-fold	NULL
higher	NULL
in	NULL
BL	NULL
lines	NULL
than	NULL
in	NULL
purified	NULL
CD38*	NULL
B	NULL
cells	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
A-myb	NULL
may	NULL
be	NULL
overexpressed	NULL
in	NULL
BL	NULL
and	NULL
B-ALL	NULL
cells	NULL
relative	NULL
to	NULL
normal	NULL
B	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
the	NULL
demonstration	NULL
of	NULL
such	NULL
hypothesis	NULL
will	NULL
require	NULL
analysis	NULL
of	NULL
A-myb	NULL
expression	NULL
at	NULL
the	NULL
single-cell	NULL
level	NULL
using	NULL
immunocytochemis-try	NULL
and/or	NULL
in	NULL
situ	NULL
hybridization	NULL
.	NULL

Such	NULL
studies	NULL
are	NULL
in	NULL
progress	NULL
.	NULL

In	NULL
this	NULL
respect	NULL
it	NULL
is	NULL
rather	NULL
intriguing	NULL
that	NULL
the	NULL
A-myb	NULL
genome	NULL
has	NULL
been	NULL
localized	NULL
on	NULL
chromosome	NULL
8q22-23	NULL
,	NULL
``	NULL
°	NULL
which	NULL
is	NULL
rela-	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
tively	NULL
close	NULL
to	NULL
the	NULL
c-myc	NULL
gene	NULL
(	NULL
84924	NULL
)	NULL
.	NULL

However	NULL
,	NULL
standard	NULL
or	NULL
pulse-field	NULL
Southern	NULL
analysis	NULL
using	NULL
the	NULL
A-myb	NULL
complete	NULL
cDNA	NULL
as	NULL
probe	NULL
has	NULL
not	NULL
shown	NULL
any	NULL
rearrangement	NULL
of	NULL
A-myb	NULL
and	NULL
has	NULL
not	NULL
allowed	NULL
to	NULL
evaluate	NULL
the	NULL
real	NULL
distance	NULL
between	NULL
A-myb	NULL
and	NULL
the	NULL
breakpoints	NULL
located	NULL
far	NULL
upstream	NULL
of	NULL
c-myc	NULL
present	NULL
in	NULL
some	NULL
cell	NULL
lines	NULL
(	NULL
Daudi	NULL
,	NULL
AG876	NULL
)	NULL
.	NULL

``	NULL
``	NULL
``	NULL
°	NULL
Also	NULL
,	NULL
deregulation	NULL
of	NULL
c-myc	NULL
as	NULL
tested	NULL
in	NULL
EBV-LCL	NULL
transfected	NULL
with	NULL
a	NULL
c-mye	NULL
construct	NULL
did	NULL
not	NULL
lead	NULL
to	NULL
induction	NULL
of	NULL
A-myb	NULL
expression	NULL
,	NULL
suggesting	NULL
that	NULL
a	NULL
deregulated	NULL
c-myc	NULL
is	NULL
not	NULL
directly	NULL
causative	NULL
of	NULL
A-myb	NULL
expression	NULL
,	NULL
at	NULL
least	NULL
in	NULL
this	NULL
cellular	NULL
background	NULL
.	NULL

``	NULL
*	NULL
``	NULL
We	NULL
have	NULL
also	NULL
investigated	NULL
in	NULL
the	NULL
cases	NULL
of	NULL
BL	NULL
lines	NULL
and	NULL
CLL	NULL
whether	NULL
A-myb	NULL
expression	NULL
correlated	NULL
with	NULL
that	NULL
of	NULL
c-myc	NULL
,	NULL
but	NULL
found	NULL
no	NULL
evidence	NULL
that	NULL
this	NULL
is	NULL
the	NULL
case	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
have	NULL
no	NULL
direct	NULL
evidence	NULL
of	NULL
a	NULL
relationship	NULL
between	NULL
c-myc	NULL
rearrangement	NULL
or	NULL
regulation	NULL
and	NULL
A-myb	NULL
expression	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
A-myb	NULL
was	NULL
also	NULL
strongly	NULL
expressed	NULL
in	NULL
about	NULL
25	NULL
%	NULL
of	NULL
CLL	NULL
samples	NULL
was	NULL
rather	NULL
surprising	NULL
because	NULL
these	NULL
cells	NULL
have	NULL
a	NULL
very	NULL
different	NULL
phenotype	NULL
,	NULL
behavior	NULL
and	NULL
cellular	NULL
origin	NULL
from	NULL
BL	NULL
or	NULL
B-ALL	NULL
cells	NULL
.	NULL

``	NULL
*	NULL
``	NULL
``	NULL
Indeed	NULL
,	NULL
it	NULL
has	NULL
been	NULL
hypothesized	NULL
that	NULL
CLL	NULL
cells	NULL
originate	NULL
from	NULL
a	NULL
distinct	NULL
B-cell	NULL
lineage	NULL
(	NULL
B1	NULL
)	NULL
whereas	NULL
most	NULL
other	NULL
B-cell	NULL
neoplasias	NULL
derive	NULL
from	NULL
B2	NULL
lineage	NULL
cells	NULL
.	NULL

**	NULL
``	NULL
``	NULL
``	NULL
'	NULL
We	NULL
do	NULL
not	NULL
know	NULL
whether	NULL
A-myb	NULL
is	NULL
expressed	NULL
in	NULL
the	NULL
rare	NULL
normal	NULL
B1	NULL
cells	NULL
and	NULL
therefore	NULL
whether	NULL
A-myb	NULL
expression	NULL
reflects	NULL
the	NULL
phenotype	NULL
of	NULL
their	NULL
normal	NULL
counterpart	NULL
.	NULL

Normal	NULL
and	NULL
neoplastic	NULL
B1	NULL
cells	NULL
can	NULL
be	NULL
CDS*	NULL
or	NULL
CDSC	NULL
.	NULL

*	NULL
``	NULL
°	NULL
``	NULL
``	NULL
A-myb	NULL
expression	NULL
in	NULL
CLL	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
expression	NULL
of	NULL
CDS	NULL
or	NULL
other	NULL
markers	NULL
such	NULL
as	NULL
CD23	NULL
,	NULL
CD38	NULL
,	NULL
or	NULL
CD39	NULL
.	NULL

The	NULL
heterogeneity	NULL
of	NULL
expression	NULL
in	NULL
CLL	NULL
did	NULL
not	NULL
correlate	NULL
either	NULL
with	NULL
clinical	NULL
parameters	NULL
such	NULL
as	NULL
stage	NULL
of	NULL
the	NULL
disease	NULL
.	NULL

Although	NULL
the	NULL
role	NULL
of	NULL
A-myb	NULL
expression	NULL
in	NULL
CLL	NULL
remains	NULL
unclear	NULL
,	NULL
it	NULL
provides	NULL
a	NULL
new	NULL
marker	NULL
of	NULL
heterogeneity	NULL
for	NULL
this	NULL
leukemia	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
data	NULL
confirm	NULL
the	NULL
hypothesis	NULL
that	NULL
A-myb	NULL
expression	NULL
is	NULL
specific	NULL
for	NULL
a	NULL
restricted	NULL
stage	NULL
(	NULL
s	NULL
)	NULL
of	NULL
B-cell	NULL
differentiation	NULL
rather	NULL
than	NULL
associated	NULL
to	NULL
a	NULL
high	NULL
proliferation	NULL
rate	NULL
because	NULL
CLL	NULL
cells	NULL
are	NULL
rather	NULL
slow	NULL
growing	NULL
.	NULL
``	NULL

We	NULL
have	NULL
also	NULL
been	NULL
able	NULL
to	NULL
study	NULL
progression	NULL
of	NULL
a	NULL
CLL	NULL
case	NULL
into	NULL
RS	NULL
in	NULL
a	NULL
patient	NULL
whose	NULL
PB	NULL
contained	NULL
both	NULL
cell	NULL
populations	NULL
distinguishable	NULL
on	NULL
the	NULL
basis	NULL
of	NULL
size	NULL
and	NULL
phenotype	NULL
.	NULL

The	NULL
Richter	NULL
's	NULL
cells	NULL
were	NULL
likely	NULL
to	NULL
be	NULL
derived	NULL
from	NULL
the	NULL
original	NULL
CLL	NULL
cells	NULL
,	NULL
as	NULL
described	NULL
for	NULL
most	NULL
other	NULL
Richter	NULL
's	NULL
cases	NULL
,	NULL
``	NULL
``	NULL
because	NULL
both	NULL
carried	NULL
the	NULL
\	NULL
light-chain	NULL
isotype	NULL
.	NULL

Progression	NULL
was	NULL
accompanied	NULL
by	NULL
a	NULL
loss	NULL
of	NULL
CDS	NULL
expression	NULL
and	NULL
by	NULL
an	NULL
approximately	NULL
25-fold	NULL
decrease	NULL
in	NULL
A-myb	NULL
expression	NULL
.	NULL

Thus	NULL
,	NULL
once	NULL
again	NULL
the	NULL
change	NULL
in	NULL
A-myb	NULL
expression	NULL
in	NULL
this	NULL
case	NULL
did	NULL
not	NULL
correlate	NULL
with	NULL
proliferation	NULL
but	NULL
with	NULL
a	NULL
shift	NULL
in	NULL
differentiation	NULL
.	NULL

Studies	NULL
aimed	NULL
at	NULL
defining	NULL
the	NULL
biologic	NULL
function	NULL
of	NULL
the	NULL
A-myb	NULL
transcription	NULL
factor	NULL
in	NULL
B	NULL
lymphocytes	NULL
will	NULL
be	NULL
necessary	NULL
to	NULL
understand	NULL
its	NULL
role	NULL
in	NULL
the	NULL
neoplasms	NULL
studied	NULL
here	NULL
.	NULL

C-myb	NULL
and	NULL
B-myb	NULL
showed	NULL
a	NULL
quite	NULL
different	NULL
pattern	NULL
of	NULL
expression	NULL
.	NULL

They	NULL
were	NULL
expressed	NULL
in	NULL
most	NULL
cell	NULL
lines	NULL
of	NULL
all	NULL
neoplastic	NULL
groups	NULL
,	NULL
although	NULL
their	NULL
expression	NULL
was	NULL
somewhat	NULL
heterogeneous	NULL
within	NULL
each	NULL
group	NULL
.	NULL

Among	NULL
fresh	NULL
cases	NULL
,	NULL
c-myb	NULL
and	NULL
B-myb	NULL
were	NULL
again	NULL
expressed	NULL
in	NULL
most	NULL
ALL	NULL
samples	NULL
,	NULL
whatever	NULL
their	NULL
subtype	NULL
.	NULL

On	NULL
the	NULL
contrary	NULL
,	NULL
only	NULL
3	NULL
of	NULL
20	NULL
CLL	NULL
showed	NULL
some	NULL
c-myb	NULL
expression	NULL
and	NULL
none	NULL
had	NULL
detectable	NULL
B-myb	NULL
.	NULL

These	NULL
data	NULL
are	NULL
in	NULL
agreement	NULL
with	NULL
previous	NULL
data	NULL
,	NULL
suggesting	NULL
that	NULL
in	NULL
mature	NULL
lymphoid	NULL
cells	NULL
,	NULL
c-myb	NULL
and	NULL
B-myb	NULL
expression	NULL
correlates	NULL
with	NULL
proliferation	NULL
,	NULL
'*	NULL
``	NULL
``	NULL
because	NULL
CLL	NULL
1909	NULL
usually	NULL
have	NULL
a	NULL
low	NULL
mitotic	NULL
index	NULL
.	NULL
``	NULL

Interestingly	NULL
,	NULL
c-myb	NULL
was	NULL
expressed	NULL
even	NULL
in	NULL
very	NULL
mature	NULL
(	NULL
myeloma	NULL
)	NULL
cell	NULL
lines	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
gene	NULL
is	NULL
expressed	NULL
throughout	NULL
B-cell	NULL
differentia-tion	NULL
,	NULL
although	NULL
generally	NULL
at	NULL
lower	NULL
levels	NULL
in	NULL
mature	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
myelomas	NULL
,	NULL
EBV-LCL	NULL
,	NULL
BL	NULL
)	NULL
than	NULL
in	NULL
immature	NULL
ones	NULL
(	NULL
null	NULL
and	NULL
common	NULL
ALL	NULL
)	NULL
,	NULL
as	NULL
suggested	NULL
previously	NULL
for	NULL
murine	NULL
B-cell	NULL
differentiation	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
the	NULL
latter	NULL
case	NULL
the	NULL
decrease	NULL
in	NULL
c-myb	NULL
expression	NULL
from	NULL
pre-B	NULL
to	NULL
plasmacytoma	NULL
lines	NULL
appeared	NULL
to	NULL
be	NULL
more	NULL
consistent	NULL
than	NULL
that	NULL
observed	NULL
here	NULL
and	NULL
the	NULL
c-myb	NULL
mRNA	NULL
was	NULL
hardly	NULL
detectable	NULL
in	NULL
the	NULL
murine	NULL
plasmacytoma	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
we	NULL
could	NULL
easily	NULL
detect	NULL
c-myb	NULL
mRNA	NULL
expression	NULL
in	NULL
the	NULL
mature	NULL
human	NULL
lines	NULL
and	NULL
in	NULL
a	NULL
few	NULL
cases	NULL
even	NULL
at	NULL
quite	NULL
high	NULL
levels	NULL
(	NULL
immunoblastic	NULL
lymphomas	NULL
)	NULL
,	NULL
confirming	NULL
that	NULL
c-myb	NULL
expression	NULL
is	NULL
not	NULL
only	NULL
related	NULL
to	NULL
differentiation	NULL
.	NULL

Of	NULL
note	NULL
is	NULL
that	NULL
no	NULL
evidence	NULL
of	NULL
gross	NULL
structural	NULL
abnormality	NULL
of	NULL
c-myb	NULL
or	NULL
B-myb	NULL
could	NULL
be	NULL
detected	NULL
in	NULL
the	NULL
different	NULL
leukemic	NULL
samples	NULL
studied	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
A-myb	NULL
expression	NULL
in	NULL
neoplastic	NULL
B	NULL
cells	NULL
is	NULL
distinct	NULL
and	NULL
more	NULL
restricted	NULL
than	NULL
that	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
data	NULL
clearly	NULL
show	NULL
that	NULL
A-myb	NULL
expression	NULL
does	NULL
not	NULL
correlate	NULL
with	NULL
proliferation	NULL
,	NULL
because	NULL
A-myb	NULL
is	NULL
absent	NULL
from	NULL
many	NULL
rapidly	NULL
proliferating	NULL
cells	NULL
(	NULL
eg	NULL
,	NULL
ALL	NULL
,	NULL
RS	NULL
,	NULL
PLL	NULL
)	NULL
and	NULL
on	NULL
the	NULL
contrary	NULL
is	NULL
present	NULL
in	NULL
cells	NULL
with	NULL
a	NULL
low	NULL
mitotic	NULL
index	NULL
(	NULL
eg	NULL
,	NULL
some	NULL
CLL	NULL
)	NULL
.	NULL

Similarly	NULL
A-myb	NULL
,	NULL
unlike	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
was	NULL
not	NULL
induced	NULL
during	NULL
mitogenic	NULL
stimulation	NULL
of	NULL
normal	NULL
B	NULL
lymphocytes	NULL
in	NULL
The	NULL
very	NULL
different	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
A-myb	NULL
relative	NULL
to	NULL
c-myb	NULL
and	NULL
B-myb	NULL
is	NULL
interesting	NULL
because	NULL
these	NULL
three	NULL
myb	NULL
proteins	NULL
share	NULL
several	NULL
biochemical	NULL
functions	NULL
.	NULL

``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
*	NULL
``	NULL
They	NULL
all	NULL
recognize	NULL
the	NULL
same	NULL
DNA	NULL
sequence	NULL
and	NULL
can	NULL
activate	NULL
transcription	NULL
in	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
although	NULL
A-myb	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
most	NULL
active	NULL
member	NULL
of	NULL
the	NULL
family	NULL
,	NULL
``	NULL
``	NULL
leading	NULL
to	NULL
the	NULL
hypothesis	NULL
that	NULL
the	NULL
different	NULL
myb	NULL
genes	NULL
may	NULL
have	NULL
redundant	NULL
roles	NULL
.	NULL

However	NULL
,	NULL
the	NULL
specific	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
these	NULL
genes	NULL
,	NULL
and	NULL
in	NULL
particular	NULL
of	NULL
A-myb	NULL
,	NULL
indicates	NULL
that	NULL
they	NULL
have	NULL
on	NULL
the	NULL
contrary	NULL
distinct	NULL
biologic	NULL
functions	NULL
in	NULL
hematopoietic	NULL
cells	NULL
,	NULL
perhaps	NULL
through	NULL
interaction	NULL
with	NULL
different	NULL
sets	NULL
of	NULL
partners	NULL
.	NULL
``	NULL

''	NULL
Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
correlation	NULL
between	NULL
A-myb	NULL
expression	NULL
and	NULL
proliferation	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
points	NULL
to	NULL
a	NULL
role	NULL
of	NULL
A-myb	NULL
in	NULL
one	NULL
or	NULL
more	NULL
of	NULL
the	NULL
differentiation	NULL
processes	NULL
taking	NULL
place	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

A-myb	NULL
expression	NULL
has	NULL
also	NULL
been	NULL
studied	NULL
in	NULL
Xenopus	NULL
and	NULL
in	NULL
the	NULL
developing	NULL
mouse	NULL
.	NULL
``	NULL

In	NULL
Xen-opus	NULL
,	NULL
A-myb	NULL
appears	NULL
to	NULL
be	NULL
most	NULL
highly	NULL
expressed	NULL
in	NULL
immature	NULL
proliferating	NULL
spermatogonia	NULL
and	NULL
ovarian	NULL
tissue	NULL
.	NULL
``	NULL

In	NULL
the	NULL
mouse	NULL
,	NULL
A-myb	NULL
is	NULL
restricted	NULL
to	NULL
mitotically	NULL
active	NULL
cells	NULL
of	NULL
the	NULL
developing	NULL
central	NULL
nervous	NULL
system	NULL
,	NULL
adult	NULL
testis	NULL
,	NULL
and	NULL
in	NULL
B	NULL
lymphocytes	NULL
of	NULL
germinal	NULL
centers	NULL
.	NULL
``	NULL

'	NULL
A-myb	NULL
in	NULL
the	NULL
latter	NULL
systems	NULL
was	NULL
hypothesized	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
control	NULL
of	NULL
a	NULL
proliferation	NULL
and/or	NULL
differentiation	NULL
step	NULL
preceding	NULL
final	NULL
differentiation	NULL
in	NULL
several	NULL
cell	NULL
types	NULL
.	NULL
``	NULL

The	NULL
data	NULL
presented	NULL
here	NULL
point	NULL
to	NULL
a	NULL
role	NULL
of	NULL
A-myb	NULL
in	NULL
B-lymphocyte	NULL
differentiation	NULL
.	NULL

Because	NULL
deregulation	NULL
of	NULL
differentiation	NULL
is	NULL
commonly	NULL
observed	NULL
in	NULL
cancer	NULL
,	NULL
further	NULL
study	NULL
of	NULL
the	NULL
role	NULL
of	NULL
A-myb	NULL
in	NULL
the	NULL
biology	NULL
and	NULL
transformation	NULL
of	NULL
the	NULL
B-cell	NULL
neoplasias	NULL
presented	NULL
here	NULL
is	NULL
warranted	NULL
.	NULL

Stable	NULL
B-cell	NULL
transfectants	NULL
of	NULL
A-myb	NULL
are	NULL
being	NULL
generated	NULL
to	NULL
investigate	NULL
this	NULL
question	NULL
further	NULL
.	NULL

ACKNOWLEDGMENT	NULL
We	NULL
thank	NULL
G.	NULL
Moldenhauer	NULL
,	NULL
H.	NULL
Stein	NULL
,	NULL
T.	NULL
Tursz	NULL
,	NULL
D.	NULL
Rowe	NULL
,	NULL
A.	NULL
Rick-inson	NULL
,	NULL
and	NULL
P.C.L	NULL
.	NULL

Beverley	NULL
for	NULL
their	NULL
kind	NULL
gifts	NULL
of	NULL
reagents	NULL
.	NULL

We	NULL
also	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

1910	NULL
are	NULL
grateful	NULL
to	NULL
S.	NULL
Bernasconi	NULL
for	NULL
his	NULL
technical	NULL
assistance	NULL
and	NULL
G.	NULL
Andreoni	NULL
for	NULL
his	NULL
help	NULL
with	NULL
the	NULL
densitometric	NULL
analysis	NULL
.	NULL

We	NULL
thank	NULL
F.	NULL
and	NULL
V.	NULL
De	NULL
Ceglie	NULL
for	NULL
the	NULL
photographic	NULL
work	NULL
.	NULL

This	NULL
paper	NULL
is	NULL
dedicated	NULL
to	NULL
the	NULL
memory	NULL
of	NULL
Prof.	NULL
A.	NULL
Leonardi	NULL
,	NULL
general	NULL
secretary	NULL
of	NULL
the	NULL
``	NULL
'Mario	NULL
Negri*	NULL
'	NULL
Institute	NULL
,	NULL
who	NULL
sadly	NULL
passed	NULL
away	NULL
while	NULL
this	NULL
manuscript	NULL
was	NULL
in	NULL
preparation	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Nomura	NULL
N	NULL
,	NULL
Takahashi	NULL
M	NULL
,	NULL
Matsui	NULL
M	NULL
,	NULL
Ishii	NULL
S	NULL
,	NULL
Date	NULL
T	NULL
,	NULL
Sasamoto	NULL
S	NULL
,	NULL
Ishizaki	NULL
R	NULL
:	NULL
Isolation	NULL
of	NULL
human	NULL
cDNA	NULL
clones	NULL
of	NULL
myb-related	NULL
genes	NULL
,	NULL
A-myb	NULL
and	NULL
B-myb	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
16:11075	NULL
,	NULL
1988	NULL
2	NULL
.	NULL

Golay	NULL
J	NULL
,	NULL
Loffarelli	NULL
L	NULL
,	NULL
Luppi	NULL
M	NULL
,	NULL
Castellano	NULL
M	NULL
,	NULL
Introna	NULL
M	NULL
:	NULL
The	NULL
human	NULL
A-myb	NULL
protein	NULL
is	NULL
a	NULL
strong	NULL
activator	NULL
of	NULL
transcription	NULL
.	NULL

Oncogene	NULL
9:2469	NULL
,	NULL
1994	NULL
3	NULL
.	NULL

Radke	NULL
K	NULL
,	NULL
Beug	NULL
H	NULL
,	NULL
Kornfeld	NULL
S	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
Transformation	NULL
of	NULL
both	NULL
erythroid	NULL
and	NULL
myeloid	NULL
cells	NULL
by	NULL
E26	NULL
,	NULL
an	NULL
avian	NULL
leukemia	NULL
virus	NULL
that	NULL
contains	NULL
the	NULL
myb	NULL
gene	NULL
.	NULL

Cell	NULL
31:643	NULL
,	NULL
1982	NULL
4	NULL
.	NULL

Beug	NULL
H	NULL
,	NULL
Leutz	NULL
A	NULL
,	NULL
Khan	NULL
P	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
Ts	NULL
mutants	NULL
of	NULL
E26	NULL
leukemia	NULL
virus	NULL
allow	NULL
transformed	NULL
myeloblasts	NULL
,	NULL
but	NULL
not	NULL
erythroblasts	NULL
or	NULL
fibro-blasts	NULL
,	NULL
to	NULL
differentiate	NULL
at	NULL
the	NULL
nonpermissive	NULL
temperature	NULL
.	NULL

Cell	NULL
39:579	NULL
,	NULL
1984	NULL
5	NULL
.	NULL

Introna	NULL
M	NULL
,	NULL
Luchetti	NULL
M	NULL
,	NULL
Castellano	NULL
M	NULL
,	NULL
Arsura	NULL
M	NULL
,	NULL
Golay	NULL
J	NULL
:	NULL
The	NULL
myb	NULL
oncogene	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
:	NULL
Potent	NULL
regulators	NULL
of	NULL
hematopoietic	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
.	NULL

Semin	NULL
Cancer	NULL
Biol	NULL
5:113	NULL
,	NULL
1993	NULL
6	NULL
.	NULL

Gewirtz	NULL
AM	NULL
,	NULL
Calabretta	NULL
B	NULL
:	NULL
A	NULL
c-myb	NULL
antisense	NULL
oligodeoxy-nucleotide	NULL
inhibits	NULL
normal	NULL
human	NULL
hematopoiesis	NULL
in	NULL
vitro	NULL
.	NULL

Science	NULL
242:1303	NULL
,	NULL
1988	NULL
7	NULL
.	NULL

Clarke	NULL
MF	NULL
,	NULL
Kukowska	NULL
Latallo	NULL
JF	NULL
,	NULL
Westin	NULL
E	NULL
,	NULL
Smith	NULL
M	NULL
,	NULL
Pro-chownik	NULL
EV	NULL
:	NULL
Constitutive	NULL
expression	NULL
of	NULL
a	NULL
c-myb	NULL
cDNA	NULL
blocks	NULL
Friend	NULL
murine	NULL
erythroleukemia	NULL
cell	NULL
differentiation	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
8:884	NULL
,	NULL
1988	NULL
8	NULL
.	NULL

Introna	NULL
M	NULL
,	NULL
Golay	NULL
J	NULL
,	NULL
Frampton	NULL
J	NULL
,	NULL
Nakano	NULL
T	NULL
,	NULL
Ness	NULL
S	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
Mutations	NULL
in	NULL
the	NULL
v-myb	NULL
alter	NULL
the	NULL
differentiation	NULL
of	NULL
myelomonocytic	NULL
cells	NULL
transformed	NULL
by	NULL
the	NULL
oncogene	NULL
.	NULL

Cell	NULL
63:1287	NULL
,	NULL
1990	NULL
9	NULL
.	NULL

Mucenski	NULL
ML	NULL
,	NULL
McLain	NULL
K	NULL
,	NULL
Kier	NULL
AB	NULL
,	NULL
Swerdiow	NULL
SH	NULL
,	NULL
Schreiner	NULL
CM	NULL
,	NULL
Miller	NULL
TA	NULL
,	NULL
Pietryga	NULL
DW	NULL
,	NULL
Scott	NULL
WJJ	NULL
,	NULL
Potter	NULL
SS	NULL
:	NULL
A	NULL
functional	NULL
c-myb	NULL
gene	NULL
is	NULL
required	NULL
for	NULL
normal	NULL
murine	NULL
fetal	NULL
hepatic	NULL
hematopoie-sis	NULL
.	NULL

Cell	NULL
65:677	NULL
,	NULL
1991	NULL
10	NULL
.	NULL

Kastan	NULL
MB	NULL
,	NULL
Stone	NULL
KD	NULL
,	NULL
Civin	NULL
CI	NULL
:	NULL
Nuclear	NULL
oncoprotein	NULL
expression	NULL
as	NULL
a	NULL
function	NULL
of	NULL
lineage	NULL
,	NULL
differentiation	NULL
stage	NULL
,	NULL
and	NULL
proliferative	NULL
status	NULL
of	NULL
normal	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
74:1517	NULL
,	NULL
1989	NULL
11	NULL
.	NULL

Klempnauer	NULL
K-H	NULL
,	NULL
Arnold	NULL
H	NULL
,	NULL
Biedenkapp	NULL
H	NULL
:	NULL
Activation	NULL
of	NULL
transcription	NULL
by	NULL
v-myb	NULL
:	NULL
Evidence	NULL
for	NULL
two	NULL
different	NULL
mechanisms	NULL
.	NULL

Genes	NULL
Dev	NULL
3:1582	NULL
,	NULL
1989	NULL
12	NULL
.	NULL

Ness	NULL
SA	NULL
,	NULL
Marknell	NULL
A	NULL
,	NULL
Graf	NULL
T	NULL
:	NULL
The	NULL
v-myb	NULL
oncogene	NULL
product	NULL
binds	NULL
to	NULL
and	NULL
activates	NULL
the	NULL
promyelocyte-specific	NULL
mim-1	NULL
gene	NULL
.	NULL

Cell	NULL
59:1115	NULL
,	NULL
1989	NULL
13	NULL
.	NULL

Weston	NULL
K	NULL
,	NULL
Bishop	NULL
JM	NULL
:	NULL
Transcriptional	NULL
activation	NULL
by	NULL
the	NULL
v-myb	NULL
oncogene	NULL
and	NULL
its	NULL
cellular	NULL
progenitor	NULL
c-myb	NULL
.	NULL

Cell	NULL
58:85	NULL
,	NULL
1989	NULL
14	NULL
.	NULL

Biedenkapp	NULL
H	NULL
,	NULL
Borgmeyer	NULL
U	NULL
,	NULL
Sippel	NULL
AE	NULL
,	NULL
Klempnauer	NULL
KH	NULL
:	NULL
Viral	NULL
myb	NULL
oncogene	NULL
encodes	NULL
a	NULL
sequence-specific	NULL
DNA-binding	NULL
ac-tivity	NULL
.	NULL

Nature	NULL
335:835	NULL
,	NULL
1988	NULL
15	NULL
.	NULL

Lane	NULL
T	NULL
,	NULL
Ibanez	NULL
C	NULL
,	NULL
Garcia	NULL
A	NULL
,	NULL
Graf	NULL
T	NULL
,	NULL
Lipsick	NULL
J	NULL
:	NULL
Transformation	NULL
by	NULL
v-myb	NULL
correlates	NULL
with	NULL
trans-activation	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
10:2591	NULL
,	NULL
1990	NULL
16	NULL
.	NULL

Foos	NULL
G	NULL
,	NULL
Grimm	NULL
S	NULL
,	NULL
Klempnauer	NULL
KH	NULL
:	NULL
The	NULL
chicken	NULL
A-myb	NULL
protein	NULL
is	NULL
a	NULL
transcriptional	NULL
activator	NULL
.	NULL

Oncogene	NULL
9:2481	NULL
,	NULL
1994	NULL
17	NULL
.	NULL

Reiss	NULL
K	NULL
,	NULL
Travali	NULL
S	NULL
,	NULL
Calabretta	NULL
B	NULL
,	NULL
Baserga	NULL
R	NULL
:	NULL
Growth	NULL
regulated	NULL
expression	NULL
of	NULL
B-myb	NULL
in	NULL
fibroblasts	NULL
and	NULL
hematopoietic	NULL
cells	NULL
.	NULL

J	NULL
Cell	NULL
Physiol	NULL
148:338	NULL
,	NULL
1991	NULL
18	NULL
.	NULL

Golay	NULL
J	NULL
,	NULL
Capucci	NULL
A	NULL
,	NULL
Arsura	NULL
M	NULL
,	NULL
Castellano	NULL
M	NULL
,	NULL
Rizzo	NULL
V	NULL
,	NULL
Introna	NULL
M	NULL
:	NULL
Expression	NULL
of	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
but	NULL
not	NULL
A-myb	NULL
,	NULL
correlates	NULL
with	NULL
proliferation	NULL
in	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Blood	NULL
77:149	NULL
,	NULL
1991	NULL
19	NULL
.	NULL

Arsura	NULL
M	NULL
,	NULL
Introna	NULL
M	NULL
,	NULL
Passerini	NULL
F	NULL
,	NULL
Mantovani	NULL
A	NULL
,	NULL
Golay	NULL
J	NULL
:	NULL
B	NULL
GOLAY	NULL
ET	NULL
AL	NULL
myb	NULL
antisense	NULL
oligonucleotides	NULL
inhibit	NULL
proliferation	NULL
of	NULL
human	NULL
haematopoietic	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
79:2708	NULL
,	NULL
1992	NULL
20	NULL
.	NULL

Golay	NULL
J	NULL
,	NULL
Erba	NULL
E	NULL
,	NULL
Bernasconi	NULL
S	NULL
,	NULL
Peri	NULL
G	NULL
,	NULL
Introna	NULL
M	NULL
:	NULL
The	NULL
A-myb	NULL
gene	NULL
is	NULL
highly	NULL
expressed	NULL
in	NULL
tonsillar	NULL
germinal	NULL
center	NULL
CD38+	NULL
,	NULL
CD39-	NULL
,	NULL
sig	NULL
M-	NULL
B	NULL
lymphocytes	NULL
and	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

J	NULL
Immunol	NULL
153:543	NULL
,	NULL
1994	NULL
21	NULL
.	NULL

Trauth	NULL
K	NULL
,	NULL
Mutschler	NULL
B	NULL
,	NULL
Jenkins	NULL
NA	NULL
,	NULL
Gilbert	NULL
DJ	NULL
,	NULL
Copeland	NULL
NG	NULL
,	NULL
Klempnauer	NULL
KH	NULL
:	NULL
Mouse	NULL
A-myb	NULL
encodes	NULL
a	NULL
trans-activator	NULL
and	NULL
is	NULL
expressed	NULL
in	NULL
mitotically	NULL
active	NULL
cells	NULL
of	NULL
the	NULL
developing	NULL
central	NULL
nervous	NULL
system	NULL
,	NULL
adult	NULL
testis	NULL
and	NULL
B-lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
13:5994	NULL
,	NULL
1994	NULL
22	NULL
.	NULL

MacLennan	NULL
CM	NULL
:	NULL
Germinal	NULL
centers	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
12:117	NULL
,	NULL
1994	NULL
23	NULL
.	NULL

Shen	NULL
Ong	NULL
GL	NULL
,	NULL
Morse	NULL
HC	NULL
,	NULL
Potter	NULL
M	NULL
,	NULL
Mushinski	NULL
JF	NULL
:	NULL
Two	NULL
modes	NULL
of	NULL
c-myb	NULL
activation	NULL
in	NULL
virus-induced	NULL
mouse	NULL
myeloid	NULL
tumors	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
6:380	NULL
,	NULL
1986	NULL
24	NULL
.	NULL

Gonda	NULL
TJ	NULL
,	NULL
Cory	NULL
S	NULL
,	NULL
Sobieszczuk	NULL
P	NULL
,	NULL
Holtzman	NULL
D	NULL
,	NULL
Adams	NULL
JM	NULL
:	NULL
Generation	NULL
of	NULL
altered	NULL
transcripts	NULL
by	NULL
retroviral	NULL
insertion	NULL
within	NULL
the	NULL
c-myb	NULL
gene	NULL
in	NULL
two	NULL
murine	NULL
monocytic	NULL
leukemias	NULL
.	NULL

J	NULL
Virol	NULL
61:2754	NULL
,	NULL
1987	NULL
25	NULL
.	NULL

Nason-Burchenal	NULL
K	NULL
,	NULL
Wolff	NULL
L	NULL
:	NULL
Activation	NULL
of	NULL
c-myb	NULL
is	NULL
an	NULL
early	NULL
bone-marrow	NULL
event	NULL
in	NULL
a	NULL
murine	NULL
model	NULL
for	NULL
acute	NULL
promonocytic	NULL
leukemia	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:1619	NULL
,	NULL
1993	NULL
26	NULL
.	NULL

Barletta	NULL
C	NULL
,	NULL
Pelicci	NULL
PG	NULL
,	NULL
Kenyon	NULL
LC	NULL
,	NULL
Smith	NULL
SD	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Relationship	NULL
between	NULL
the	NULL
c-myb	NULL
locus	NULL
and	NULL
the	NULL
6q-	NULL
chromosomal	NULL
aberration	NULL
in	NULL
leukemias	NULL
and	NULL
lymphomas	NULL
.	NULL

Science	NULL
235:1064	NULL
,	NULL
1986	NULL
27	NULL
.	NULL

Pelicci	NULL
PG	NULL
,	NULL
Lanfrancone	NULL
L	NULL
,	NULL
Brathwaite	NULL
MD	NULL
,	NULL
Wolman	NULL
SR	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Amplification	NULL
of	NULL
the	NULL
c-myb	NULL
oncogene	NULL
in	NULL
a	NULL
case	NULL
of	NULL
human	NULL
myelogenous	NULL
leukemia	NULL
.	NULL

Science	NULL
224	NULL
:	NULL
1117	NULL
,	NULL
1984	NULL
28	NULL
.	NULL

Baer	NULL
MR	NULL
,	NULL
Augustinos	NULL
P	NULL
,	NULL
Kinniburgh	NULL
AJ	NULL
:	NULL
Defective	NULL
c-myc	NULL
and	NULL
c-myb	NULL
RNA	NULL
turnover	NULL
in	NULL
acute	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
.	NULL

Blood	NULL
79:1319	NULL
,	NULL
1992	NULL
29	NULL
.	NULL

Jacobs	NULL
SM	NULL
,	NULL
Gorse	NULL
KM	NULL
,	NULL
Kennedy	NULL
SJ	NULL
,	NULL
Westin	NULL
EH	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
rearrangement	NULL
in	NULL
the	NULL
c-myb	NULL
promoter	NULL
in	NULL
the	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
cell	NULL
line	NULL
CCRF-CEM	NULL
.	NULL

Cancer	NULL
Genet	NULL
Cyto-genet	NULL
75:39	NULL
,	NULL
1994	NULL
30	NULL
.	NULL

Westin	NULL
EH	NULL
,	NULL
Gallo	NULL
RC	NULL
,	NULL
Arya	NULL
SK	NULL
,	NULL
Eva	NULL
A	NULL
,	NULL
Souza	NULL
LM	NULL
,	NULL
Baluda	NULL
MA	NULL
,	NULL
Aaronson	NULL
SA	NULL
,	NULL
Wong-Staal	NULL
F	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
the	NULL
amy	NULL
gene	NULL
in	NULL
human	NULL
hematopoietic	NULL
cells	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
79:2194	NULL
,	NULL
1982	NULL
31	NULL
.	NULL

Bender	NULL
TP	NULL
,	NULL
Kuehl	NULL
WM	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
the	NULL
c-myb	NULL
proto-oncogene	NULL
marks	NULL
the	NULL
pre-B	NULL
cell/B	NULL
cell	NULL
junction	NULL
in	NULL
murine	NULL
B	NULL
lymphoid	NULL
tumors	NULL
.	NULL

J	NULL
Immunol	NULL
139:3822	NULL
,	NULL
1987	NULL
32	NULL
.	NULL

Rowe	NULL
M	NULL
,	NULL
Rooney	NULL
CM	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Lenoir	NULL
GM	NULL
,	NULL
Rupani	NULL
H	NULL
,	NULL
Moss	NULL
DJ	NULL
,	NULL
Stein	NULL
H	NULL
,	NULL
Epstein	NULL
MA	NULL
:	NULL
Distinctions	NULL
between	NULL
endemic	NULL
and	NULL
sporadic	NULL
forms	NULL
of	NULL
Epstein	NULL
Barr	NULL
virus-positive	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
35:435	NULL
,	NULL
1985	NULL
33	NULL
.	NULL

Tweeddale	NULL
ME	NULL
,	NULL
Lim	NULL
B	NULL
,	NULL
Jamal	NULL
N	NULL
,	NULL
Robinson	NULL
J	NULL
,	NULL
Zalcberg	NULL
J	NULL
,	NULL
Lockwood	NULL
G	NULL
,	NULL
Minden	NULL
MD	NULL
,	NULL
Messner	NULL
HA	NULL
:	NULL
The	NULL
presence	NULL
of	NULL
clonogenic	NULL
cells	NULL
in	NULL
high	NULL
grade	NULL
malignant	NULL
lymphoma	NULL
:	NULL
A	NULL
prognostic	NULL
factor	NULL
.	NULL

Blood	NULL
69.1307	NULL
,	NULL
1987	NULL
34	NULL
.	NULL

Lombardi	NULL
L	NULL
,	NULL
Newcomb	NULL
EW	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Pathogenesis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
:	NULL
Expression	NULL
of	NULL
an	NULL
activated	NULL
c-myc	NULL
oncogene	NULL
causes	NULL
the	NULL
tumorigenic	NULL
conversion	NULL
of	NULL
EBV-infected	NULL
human	NULL
B	NULL
lymphoblasts	NULL
.	NULL

Cell	NULL
49:161	NULL
,	NULL
1987	NULL
35	NULL
.	NULL

Gregory	NULL
CD	NULL
,	NULL
Rowe	NULL
M	NULL
,	NULL
Rickinson	NULL
AD	NULL
,	NULL
Hardie	NULL
D	NULL
,	NULL
Ling	NULL
NR	NULL
:	NULL
Lymphoblastoid	NULL
progression	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cells	NULL
in	NULL
vitro	NULL
.	NULL

A	NULL
study	NULL
with	NULL
a	NULL
panel	NULL
of	NULL
antibodies	NULL
,	NULL
in	NULL
McMichael	NULL
AJ	NULL
(	NULL
ed	NULL
)	NULL
:	NULL
Leukocyte	NULL
Typing	NULL
III	NULL
.	NULL

Oxford	NULL
,	NULL
UK	NULL
,	NULL
Oxford	NULL
University	NULL
Press	NULL
,	NULL
1986	NULL
36	NULL
.	NULL

Barletta	NULL
C	NULL
,	NULL
Druck	NULL
T	NULL
,	NULL
LaForgia	NULL
S	NULL
,	NULL
Calabretta	NULL
B	NULL
,	NULL
Drabkin	NULL
H	NULL
,	NULL
Patterson	NULL
D	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Huebner	NULL
K	NULL
:	NULL
Chromosome	NULL
locations	NULL
of	NULL
the	NULL
MYB	NULL
related	NULL
genes	NULL
,	NULL
A-MYB	NULL
and	NULL
B-MYB	NULL
.	NULL

Cancer	NULL
Res	NULL
51:3821	NULL
,	NULL
1991	NULL
37	NULL
.	NULL

Joos	NULL
S	NULL
,	NULL
Haluska	NULL
FG	NULL
,	NULL
Falf	NULL
MH	NULL
,	NULL
Henglein	NULL
B	NULL
,	NULL
Hameister	NULL
H	NULL
,	NULL
Croce	NULL
CM	NULL
,	NULL
Bornkamm	NULL
GW	NULL
:	NULL
Mapping	NULL
chromosomal	NULL
breakpoints	NULL
of	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

A-myb	NULL
EXPRESSION	NULL
IN	NULL
NEOPLASTIC	NULL
B	NULL
CELLS	NULL
Burkitt	NULL
's	NULL
1	NULL
(	NULL
8	NULL
;	NULL
14	NULL
)	NULL
translocations	NULL
far	NULL
upstream	NULL
of	NULL
c-myc	NULL
.	NULL

Cancer	NULL
Res	NULL
52:6547	NULL
,	NULL
1992	NULL
38	NULL
.	NULL

Neri	NULL
A	NULL
,	NULL
Barriga	NULL
F	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Magrath	NULL
IT	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Different	NULL
regions	NULL
of	NULL
the	NULL
immunoglobulin	NULL
heavy-chain	NULL
locus	NULL
are	NULL
involved	NULL
in	NULL
chromosomal	NULL
translocations	NULL
in	NULL
distinct	NULL
pathogenetic	NULL
forms	NULL
of	NULL
Burkitt	NULL
lymphoma	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
85:2748	NULL
,	NULL
1988	NULL
39	NULL
.	NULL

Ma	NULL
X-P	NULL
,	NULL
Calabretta	NULL
B	NULL
:	NULL
DNA	NULL
binding	NULL
and	NULL
transactivation	NULL
activity	NULL
of	NULL
A-myb	NULL
,	NULL
a	NULL
c-myb	NULL
related	NULL
gene	NULL
.	NULL

Cancer	NULL
Res	NULL
54:6512	NULL
,	NULL
1994	NULL
40	NULL
.	NULL

Liischer	NULL
B	NULL
,	NULL
Eisenman	NULL
RN	NULL
:	NULL
mitosis-specific	NULL
phosphorylation	NULL
of	NULL
the	NULL
nuclear	NULL
oncoproteins	NULL
myc	NULL
and	NULL
myb	NULL
.	NULL

J	NULL
Cell	NULL
Biol	NULL
118:775	NULL
,	NULL
1992	NULL
41	NULL
.	NULL

Arsura	NULL
M	NULL
,	NULL
Luchetti	NULL
M	NULL
,	NULL
Erba	NULL
E	NULL
,	NULL
Golay	NULL
J	NULL
,	NULL
Rambaldi	NULL
A	NULL
,	NULL
Introna	NULL
M	NULL
:	NULL
Dissociation	NULL
between	NULL
p93-B-myb	NULL
and	NULL
p75	NULL
c-myb	NULL
expression	NULL
during	NULL
the	NULL
proliferation	NULL
and	NULL
differentiation	NULL
of	NULL
human	NULL
myeloid	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
83:778	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Takemoto	NULL
Y	NULL
,	NULL
Tashiro	NULL
S	NULL
,	NULL
Handa	NULL
H	NULL
,	NULL
Ishii	NULL
S	NULL
:	NULL
Multiple	NULL
nuclear	NULL
localization	NULL
signals	NULL
of	NULL
the	NULL
B-myb	NULL
gene	NULL
product	NULL
.	NULL

FEBS	NULL
Lett	NULL
350:55	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

Magrath	NULL
I	NULL
:	NULL
The	NULL
pathogenesis	NULL
of	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

Adv	NULL
Cancer	NULL
Res	NULL
55:134	NULL
,	NULL
1990	NULL
44	NULL
.	NULL

Ling	NULL
NR	NULL
,	NULL
Hardie	NULL
D	NULL
,	NULL
Lowe	NULL
J	NULL
,	NULL
Johnson	NULL
GD	NULL
,	NULL
Khan	NULL
M	NULL
,	NULL
MacLennan	NULL
ICM	NULL
:	NULL
A	NULL
phenotypic	NULL
study	NULL
of	NULL
cells	NULL
from	NULL
Burkitt	NULL
Lymphoma	NULL
and	NULL
EBV-B-lymphoblastoid	NULL
lines	NULL
and	NULL
their	NULL
relationship	NULL
to	NULL
cells	NULL
in	NULL
normal	NULL
lymphoid	NULL
tissues	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
43:112	NULL
,	NULL
1989	NULL
45	NULL
.	NULL

Ehlin-Henriksson	NULL
B	NULL
,	NULL
Manneborg-Sandlung	NULL
A	NULL
,	NULL
Klein	NULL
G	NULL
:	NULL
Expression	NULL
of	NULL
B-cell-specific	NULL
markers	NULL
in	NULL
different	NULL
Burkitt	NULL
lymphoma	NULL
subgroups	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
39:211	NULL
,	NULL
1987	NULL
46	NULL
.	NULL

Inghirami	NULL
G	NULL
,	NULL
Grignani	NULL
F	NULL
,	NULL
Stemas	NULL
L	NULL
,	NULL
Lombardi	NULL
L	NULL
,	NULL
Knowles	NULL
DM	NULL
,	NULL
Dalla-Favera	NULL
R	NULL
:	NULL
Down	NULL
regulation	NULL
of	NULL
LFA-1	NULL
adhesion	NULL
receptors	NULL
by	NULL
c-myc	NULL
oncogene	NULL
in	NULL
human	NULL
B	NULL
lymphoblastoid	NULL
cells	NULL
.	NULL

Science	NULL
250:682	NULL
,	NULL
1990	NULL
47	NULL
.	NULL

Caligiuri	NULL
MA	NULL
,	NULL
Reeds	NULL
J	NULL
:	NULL
Immunology	NULL
of	NULL
acute	NULL
leukemias	NULL
,	NULL
in	NULL
Hendersen	NULL
S	NULL
,	NULL
Lister	NULL
PA	NULL
(	NULL
eds	NULL
)	NULL
:	NULL
Leukemia	NULL
.	NULL

Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
Saun-ders	NULL
,	NULL
1990	NULL
,	NULL
p	NULL
105	NULL
48	NULL
.	NULL

Dighiero	NULL
G	NULL
,	NULL
Travade	NULL
P	NULL
,	NULL
Chevret	NULL
S	NULL
,	NULL
Fenaux	NULL
P	NULL
,	NULL
Chastang	NULL
C	NULL
,	NULL
Binet	NULL
JL	NULL
,	NULL
The	NULL
French	NULL
Cooperative	NULL
Group	NULL
on	NULL
CLL	NULL
:	NULL
B-cell	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
:	NULL
Present	NULL
status	NULL
and	NULL
future	NULL
directions	NULL
.	NULL

Blood	NULL
78:1901	NULL
,	NULL
1991	NULL
49	NULL
.	NULL

Matolesy	NULL
A	NULL
,	NULL
Inghirami	NULL
G	NULL
,	NULL
Knowles	NULL
DM	NULL
:	NULL
Molecular	NULL
genetic	NULL
demonstration	NULL
of	NULL
the	NULL
diverse	NULL
evolution	NULL
of	NULL
Richter	NULL
's	NULL
Syndrome	NULL
(	NULL
chronic	NULL
-	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
subsequent	NULL
large	NULL
cell	NULL
lymphoma	NULL
)	NULL
.	NULL

Blood	NULL
83:1363	NULL
,	NULL
1994	NULL
50	NULL
.	NULL

Delsol	NULL
G	NULL
,	NULL
Laurent	NULL
G	NULL
,	NULL
Kuhlein	NULL
E	NULL
,	NULL
Familiades	NULL
J	NULL
,	NULL
Rigal	NULL
F	NULL
,	NULL
Pris	NULL
J	NULL
:	NULL
Richter	NULL
's	NULL
syndrome	NULL
.	NULL

Evidence	NULL
for	NULL
the	NULL
clonal	NULL
origin	NULL
of	NULL
the	NULL
two	NULL
proliferations	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
76:308	NULL
,	NULL
1981	NULL
51	NULL
.	NULL

Bertoli	NULL
LF	NULL
,	NULL
Kubagawa	NULL
H	NULL
,	NULL
Borzillo	NULL
GV	NULL
,	NULL
Mayumi	NULL
M	NULL
,	NULL
Prchal	NULL
1911	NULL
JT	NULL
,	NULL
Kearney	NULL
JF	NULL
,	NULL
Durant	NULL
JR	NULL
,	NULL
Cooper	NULL
MD	NULL
:	NULL
Analysis	NULL
with	NULL
antiidiotype	NULL
antibody	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
chronic	NULL
lymphocytic	NULL
leukemia	NULL
and	NULL
large	NULL
cell	NULL
lymphoma	NULL
(	NULL
Richter	NULL
's	NULL
syndrome	NULL
)	NULL
.	NULL

Blood	NULL
70:45	NULL
,	NULL
1987	NULL
52	NULL
.	NULL

Miyamura	NULL
K	NULL
,	NULL
Osada	NULL
H	NULL
,	NULL
Yamauchi	NULL
T	NULL
,	NULL
Itoh	NULL
M	NULL
,	NULL
Kodera	NULL
Y	NULL
,	NULL
Suchi	NULL
T	NULL
,	NULL
Takahashi	NULL
T	NULL
,	NULL
Ueda	NULL
R	NULL
:	NULL
Single	NULL
clonal	NULL
origin	NULL
of	NULL
neoplastic	NULL
B	NULL
cells	NULL
with	NULL
different	NULL
immunoglobulin	NULL
light	NULL
chains	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
Richter	NULL
's	NULL
syndrome	NULL
.	NULL

Cancer	NULL
66:140	NULL
,	NULL
1990	NULL
53	NULL
.	NULL

Chan	NULL
WC	NULL
,	NULL
Dekmezian	NULL
R	NULL
:	NULL
Phenotypic	NULL
changes	NULL
in	NULL
large	NULL
cell	NULL
transformation	NULL
of	NULL
small	NULL
cell	NULL
lymphoid	NULL
malignancies	NULL
.	NULL

Cancer	NULL
57:1971	NULL
,	NULL
1986	NULL
54	NULL
.	NULL

Schots	NULL
R	NULL
,	NULL
Dehou	NULL
MF	NULL
,	NULL
Jochmans	NULL
K	NULL
,	NULL
Heirman	NULL
C	NULL
,	NULL
De	NULL
Waele	NULL
M	NULL
,	NULL
Van	NULL
Camp	NULL
B	NULL
,	NULL
Thielemans	NULL
K	NULL
:	NULL
Southern	NULL
blot	NULL
analysis	NULL
in	NULL
a	NULL
case	NULL
of	NULL
Richter	NULL
's	NULL
syndrome	NULL
.	NULL

Am	NULL
J	NULL
Clin	NULL
Pathol	NULL
95:57	NULL
,	NULL
1991	NULL
55	NULL
.	NULL

Joshi	NULL
SS	NULL
,	NULL
DeBoer	NULL
JM	NULL
,	NULL
Strandjord	NULL
SJ	NULL
,	NULL
Pirruccelo	NULL
SJ	NULL
,	NULL
Sanger	NULL
WG	NULL
,	NULL
Weisenburger	NULL
DD	NULL
,	NULL
Sharp	NULL
JG	NULL
:	NULL
Characterization	NULL
of	NULL
a	NULL
newly	NULL
established	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
cell	NULL
line	NULL
,	NULL
OMA-BL-1	NULL
.	NULL

Int	NULL
J	NULL
Cancer	NULL
47:643	NULL
,	NULL
1991	NULL
56	NULL
.	NULL

Gregory	NULL
CD	NULL
,	NULL
Tursz	NULL
T	NULL
,	NULL
Edwards	NULL
CF	NULL
,	NULL
Tetaud	NULL
C	NULL
,	NULL
Talbot	NULL
M	NULL
,	NULL
Caillou	NULL
B	NULL
,	NULL
Rickinson	NULL
AB	NULL
,	NULL
Lipinski	NULL
M	NULL
:	NULL
Identification	NULL
of	NULL
normal	NULL
B	NULL
cells	NULL
with	NULL
a	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
BL	NULL
)	NULL
-like	NULL
phenotype	NULL
.	NULL

J	NULL
Immunol	NULL
139:313	NULL
,	NULL
1987	NULL
57	NULL
.	NULL

Liu	NULL
Y-J	NULL
,	NULL
Joshua	NULL
DE	NULL
,	NULL
William	NULL
GT	NULL
,	NULL
Smith	NULL
CA	NULL
,	NULL
Goredon	NULL
J	NULL
,	NULL
MacLennan	NULL
ICM	NULL
:	NULL
Mechanism	NULL
of	NULL
antigen	NULL
driven	NULL
selection	NULL
in	NULL
germinal	NULL
centers	NULL
.	NULL

Nature	NULL
342:929	NULL
,	NULL
1989	NULL
58	NULL
.	NULL

Gregory	NULL
CD	NULL
,	NULL
Dive	NULL
C	NULL
,	NULL
Henderson	NULL
S	NULL
,	NULL
Smith	NULL
CA	NULL
,	NULL
Williams	NULL
GT	NULL
,	NULL
Gordon	NULL
J	NULL
,	NULL
Rickinson	NULL
AB	NULL
:	NULL
Activation	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
genes	NULL
protects	NULL
human	NULL
B	NULL
cells	NULL
from	NULL
death	NULL
by	NULL
apoptosis	NULL
.	NULL

Nature	NULL
349:612	NULL
,	NULL
1991	NULL
59	NULL
.	NULL

Foon	NULL
KA	NULL
,	NULL
Rai	NULL
K	NULL
,	NULL
Gale	NULL
R	NULL
:	NULL
CLL	NULL
:	NULL
New	NULL
insights	NULL
into	NULL
biology	NULL
and	NULL
therapy	NULL
.	NULL

Ann	NULL
Intern	NULL
Med	NULL
113:525	NULL
,	NULL
1990	NULL
60	NULL
.	NULL

Herzenberg	NULL
LA	NULL
,	NULL
Stall	NULL
AM	NULL
,	NULL
Lalor	NULL
PA	NULL
,	NULL
Sidman	NULL
C	NULL
,	NULL
Moore	NULL
WA	NULL
,	NULL
Parks	NULL
DR	NULL
,	NULL
Herzenberg	NULL
LA	NULL
:	NULL
The	NULL
Ly-1	NULL
lineage	NULL
.	NULL

Immunol	NULL
Rev	NULL
93:81	NULL
,	NULL
1986	NULL
61	NULL
.	NULL

Kantor	NULL
A	NULL
:	NULL
A	NULL
new	NULL
nomenclature	NULL
for	NULL
B	NULL
cells	NULL
.	NULL

Immunol	NULL
Today	NULL
12:388	NULL
,	NULL
1991	NULL
62	NULL
.	NULL

Shipp	NULL
MA	NULL
,	NULL
Reinherz	NULL
EL	NULL
:	NULL
Differential	NULL
expression	NULL
of	NULL
nuclear	NULL
proto-oncogenes	NULL
in	NULL
T	NULL
cells	NULL
triggered	NULL
with	NULL
mitogenic	NULL
and	NULL
non-mito-genic	NULL
T3	NULL
and	NULL
Tll	NULL
activation	NULL
signals	NULL
.	NULL

J	NULL
Immunol	NULL
139:2143	NULL
,	NULL
1987	NULL
63	NULL
.	NULL

Shapiro	NULL
LH	NULL
:	NULL
Myb	NULL
and	NULL
ets	NULL
proteins	NULL
cooperate	NULL
to	NULL
transactivate	NULL
an	NULL
early	NULL
myeloid	NULL
gene	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
270:8763	NULL
,	NULL
1995	NULL
64	NULL
.	NULL

Burk	NULL
O	NULL
,	NULL
Mink	NULL
S	NULL
,	NULL
Ringwald	NULL
M	NULL
,	NULL
Klempnauer	NULL
KH	NULL
:	NULL
Synergistic	NULL
activation	NULL
of	NULL
the	NULL
chicken	NULL
mim-1	NULL
gene	NULL
by	NULL
v-myb	NULL
and	NULL
C/EBP	NULL
transcription	NULL
factors	NULL
.	NULL

EMBO	NULL
J	NULL
12:2027	NULL
,	NULL
1993	NULL
65	NULL
.	NULL

Sleeman	NULL
JP	NULL
:	NULL
Xenopus	NULL
A-myb	NULL
is	NULL
expressed	NULL
during	NULL
early	NULL
sper-matogenesis	NULL
.	NULL

Oncogene	NULL
8:193	NULL
,	NULL
1993	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blOOd	NULL
1996	NULL
87	NULL
:	NULL
1900-1911	NULL
Expression	NULL
of	NULL
A-myb	NULL
,	NULL
but	NULL
not	NULL
c-myb	NULL
and	NULL
B-myb	NULL
,	NULL
is	NULL
restricted	NULL
to	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
,	NULL
sig+	NULL
B-acute	NULL
lymphoblastic	NULL
leukemia	NULL
,	NULL
and	NULL
a	NULL
subset	NULL
of	NULL
chronic	NULL
lymphocytic	NULL
leukemias	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
\se	NULL
@	NULL
.	NULL

/	NULL
{	NULL
®	NULL
J	NULL
Golay	NULL
,	NULL
M	NULL
Luppi	NULL
,	NULL
S	NULL
Songia	NULL
,	NULL
C	NULL
Palvarini	NULL
,	NULL
L	NULL
Lombardi	NULL
,	NULL
A	NULL
Aiello	NULL
,	NULL
D	NULL
Delia	NULL
,	NULL
K	NULL
Lam	NULL
,	NULL
DH	NULL
Crawford	NULL
,	NULL
A	NULL
Biondi	NULL
,	NULL
T	NULL
Barbui	NULL
,	NULL
A	NULL
Rambaldi	NULL
and	NULL
M	NULL
Introna	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/87/5/1900.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

